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CHAPTER I 
GENERAL INTRODUCTION AND PROBLEH STATEMENT 
Caffeine is a naturally occurring methylxanthine (figure 1), 
that has been consumed and enjoyed by people throughout the world 
for many centuries. According to an ancient legend, eastern shep-
herda were the first to observe pharmacological effects of this 
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agent, as several goats showed nocturnal alertness and sleepless­
ness after eating the berries of coffee plants. Coffee was al­
ready a favourite beverage in the Middle East in the 15^^ cen­
tury, and via French and Dutch colonies coffee consumption was 
propagated and spread out to Europe in the 17th century. The 
isolation of caffeine from beans of the plant "Coffee Arabica" 
was firstly reported in 1Θ20 (1), and 55 years later its chemical 
structure was elucidated (2). 
The mean daily caffeine intake of adult coffee drinkers is 
estimated to range from 2.7 to 4 mg/kg (3). For adults weighing 
60-70 kg these estimates correspond to a daily intake of about 
160-2B0 mg caffeine. Coffee is the most important caffeine 
source, accounting for approximately 75S of total caffeine intake 
(4). In the Netherlands the mean consumption of coffee during 
1984 numbered 7.7 kg of coffee for an adult subject. The average 
caffeine content values per 150 ml (one cup) of coffee and other 
caffeine sources are: 85, 60 and 3 mg caffeine for ground roas­
ted, instant and decaffeinated coffee respectively, 40 mg for 
tea, 4 mg for cacao- and chocolate drinks and 15 mg for cola 
drinks (3). Our own data also show that one cup of coffee of 
medium strength (7.5 gram coffee/150 ml water) contains about 90 
mg caffeine (figure 2). From this figure it also appears that 
there is an almost linear relation between the quantity of coffee 
powder used, and the caffeine content per cup of coffee, when 
coffee is prepared with a coffee machine using a constant quanti­
ty of water. Decaffeinated coffee of customary strength hardly 
contains caffeine (figure 2). 
After oral ingestion caffeine is almost completely absorbed, 
and the apparent volume of distribution is between 400 and 550 
ml/kg (5). After drinking 2 cups of regular coffee peak plasma 
caffeine levels are reached after a mean of 50 minutes, and range 
between 5 and 15 mg/1 (chapter II - VI). The elimination from 
plasma occurs by demethylation and oxidation in the liver, with a 
plasma half-life averaging about 4 hr (5). As will be illustrated 
in chapter III plasma caffeine half-life shows large inter-
individual differences. Consequently, certain individuals may be 
continuously exposed to plasma caffeine concentrations, depending 
on their daily intake of caffeine. 
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Because of the widespread use of caffeine, pharmacological 
aspects of drinking coffee may be of some clinical interest. 
Around the start of the 20 t h century, caffeine and other 
methylxanthines were favourite agents for pharmacological 
studies. After a period of relative neglection, there has been a 
renewed interest in caffeine since the past 10 years. This may 
partly be the result of the increasing consciousness of the 
importance of the effects on health of all dietary components. 
Recent hypotheses on the mode of action of caffeine may also have 
contributed to this renewed interest· Although most pharmacolo-
gical effects of caffeine are subtle, and consequently hard to 
meaeure, they are not necessarily trivial, as the daily intake of 
caffeine by large numbers of people, in the long run, could bring 
about substantial effects. 
Caffeine has been reported to exert pharmacological effects in 
several organ systems! the gastrointestinal tract, the kidneys, 
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Figure 2: Caffeine content of one cup of regular or decaffeinated 
coffee, prepared by 150 ml water and different amounta 
of coffee powder (mean±SEM, n=2) 
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skeletal muscles, the central nervous system and the cardiovas-
cular system (6). Whether these effects are harmful or not has 
recently been discussed by Curatolo et al (7). With respect to 
the cardiovascular system only few pharmacological studies have 
been performed with controversial results. In 1976 important data 
on this item were published by Robertson et al (8). He observed 
an increase in blood pressure, plasma catecholamines and plasma 
renin activity after oral administration of 250 mg caffeine in 
non-coffee users, who had abstained from all caffeine-containing 
products for 3 weeks. As it is not justified to extrapolate these 
results to the effects of drinking coffee in a daily life pat-
tern, we think that the reported pressor response to caffeine 
deserves further study in man. 
Since high blood pressure is a well-documented risk factor for 
the development of cardiovascular disease (9), an acute pressor 
response to coffee (8) may have consequences for public health. 
Therefore, many investigators have been looking for a relation 
between the use of coffee and coronary heart disease. Already in 
1963, a prospective study of 1,951 men showed a positive associa-
tion between coffee consumption and ischemic heart disease (10). 
Ten years later, the Boston Collaborative Drug Surveillance Pro-
gram published their results of a multipurpose survey of 12,759 
hospitalized patients (11). They observed a 60 and 120 percent 
increased risk of acute myocardial infarction among those drin-
king respectively 1-5 and 6 or more cupa of coffee per day as 
compared to non-coffee users. These striking results elicited a 
stream of epidemiologic reports on this item. However, a lot of 
retrospective (12-15) and prospective studies (16-22) including 
the Framingham study failed to ascertain the reported relation 
between coffee ingestion and coronary heart disease. This discre-
pancy can be partly explained by differences in the number of 
variables for which the studies were controlled, for instance: 
smoking behaviour, alcohol consumption, body-mass index, physical 
activity and the use of coffee additives. A recent study, which 
was well controlled for these features, suggests that coffee con-
sumption is indeed a risk factor for coronary artery disease(23). 
A possible association between coffee consumption and cardio-
vascular mortality is not necessarily due to effects of coffee on 
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blood pressure but could also be the result of a caffeine-induced 
rise of lipoproteins (24), changes of the electrophysiologic 
properties of the heart by caffeine (25), or of a direct effect 
of coffee constituents on pathophysiological mechanisms. There-
fore, the consequences of the acute hemodynamic changes after 
caffeine may be more clearly reflected by epidemiological studies 
on the relation between the intake of coffee and the height of 
blood pressure, rather than by studies about the association 
between coffee and cardiovascular disease. On the former rela-
tion, two recent cross-sectional studies were performed by the 
same investigators on respectively 1,491 Algerian and 6,321 
French subjects, and both studies observed a positive association 
between coffee consumption and blood pressure (26,27). 
AIH OF THE STUDY 
In this thesis we will focus on the acute effects of coffee 
and caffeine on some hemodynamic and humoral parameters. As out-
lined before, Robertson et al (8) observed that after a 3-week 
period of caffeine abstention, 250 mg caffeine elicited a pressor 
response in subjects not used to coffee. Our first question was 
whether drinking coffee causes hemodynamic and or humoral changes 
in normotensive habitual coffee users, after a short abstention 
of caffeine-containing products. Secondly, we tried to find out 
whether these circulatory effects are the result of the caffeine 
load, and so similar experiments were performed with decaffeina-
ted coffee (chapter II). After chronic ingestion of caffeine, 
tolerance has been described with respect to the effects of caf-
feine on the central nervous system, diuresis, and parotid gland 
secretion (28,29,30). Recently, this has also been reported for 
the cardiovascular, both hemodynamic and humoral effects of cof-
fee and caffeine (31,32). Some of the contradictory results in 
literature concerning the cardiovascular effects of caffeine 
could be explained by these observations (32,33). In chapter III 
we study the importance of tolerance with respect to the circula-
tory effects of drinking coffee in daily life. Since the indivi-
dual pharmacokinetics of caffeine were supposed to be relevant 
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for this problem, these were taken into account. 
The literature about the hemodynamic effects of drinking 
coffee mostly refers to normotensive subjects (8,34,35). Some 
studies were performed in hypertensive patients, but those 
results were not compared to similar protocols of normotensive 
subjects (36,37). In chapter VI we report on similar coffee tests 
in hypertensive and normotensive subjects to find out whether 
hypertension may change the pressor response to coffee. 
Since caffeine increases plasma catecholamines, and especially 
adrenaline, drinking coffee could be considered as an exogenous 
stress. Treatment with non-selective ß-adrenoceptor blockade with 
propranolol alters the physiological response to experimental 
stress unfavourably, whereas this has not been observed during 
ßj-selective adrenoceptor blockade with metoprolol (38,39). 
Therefore it seemed interesting to look for differences in the 
coffee-induced hemodynamic response after p1-3elective or 
non-selective ß-adrenoceptor blockade. This subject was analysed 
in normotensive volunteers, who underwent coffee tests after pre-
treatment during one day with placebo, propranolol and metoprolol 
(chapter IV). 
Apart from analysing the acute circulatory effects of coffee 
and caffeine extensively, it seemed of importance to look for the 
pharmacological mode of action of caffeine, underlying these 
effects. Figure 3 schematically presents the most important 
mechanisms of action, supposed in the literature. Central mecha-
nisms include the stimulation of vagal centers, and of the vaso-
motor center in the medulla oblongata (40). The other putative 
modes of action can be subdivided in direct and indirect peri-
pheral actions. The latter include the caffeine-mediated stimula-
tion of the renin-angiotensin-aldosterone system and the sym-
pathoadrenal system (Θ). The direct mechanisms represent the most 
relevant possibilities for the action of methylxanthines on the 
cellular level, including:[1J the antagonism of endogenous adeno­
sine (41); [2J accumulation of intracellular cAMP by inhibition 
of phosphodiesterase (42) and [3j an increase of transmembrane 
calcium influx [3aJ, and changea in intracellular calcium mobili­
sation [ 3b and 3cJ (6). The numbers [1] to [За,bic] refer to 
figure 3. 
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The contribution of an increased transmembrane calcium influx 
to the circulatory effects of drinking coffee was studied in 
chapter V, using verapamil as a pharmacological tool. In chapter 
VI the hemodynamic and humoral effects of coffee ingestion were 
registered, both in healthy normotensive subjects as well as in 
patients with Cushing's disease, treated by bilateral adrenalec-
tomy and subsequent substitution of corticoids. The comparison 
between those groups allowed us to analyse the role of adrenaline 
with respect to the pressor response to coffee. In chapter VII we 
report on the circulatory response to exogenous adenosine after 
placebo and after 250 mg caffeine i.V.. This interaction was 
studied to gain support for the hypothesis that caffeine elevates 
blood pressure by competitive antagonism of punnergic receptor-
mediated vasodilation by endogenous adenosine. 
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CHAPTER II 
(British Journal of Clinical Pharmacology 1985; 19: Θ52-854) 
The cardiovascular effects of regular and decaffeinated coffee 
P SMITS, TH THIEN & A VAN Τ LAAR 
Division of General Internal Mediane, Department of Medicine, University of Nijmegen, Nijmegen, 
The Netherlands 
Ina single-blind study the effects of drinking two cups of regular or decaffeinated coffee on 
blood pressure, heart rate, forearm blood flow and plasma concentrations of caffeine, 
renin and catecholamines were studied in 12 normotensive subjects Drinking regular 
coffee led to a nse of blood pressure, a fall of heart rate and an increase of plasma 
catecholamines Decaffeinated coffee induced a smaller increase of diastolic blood 
pressure without changing other parameters This study shows that the cardiovascular 
effects of drinking coffee are mainly the result of its caffeine content. 
Keywords coffee decaffeinated coffee catecholamines blood pressure 
Introduction 
The pharmacological effects of caffeine have 
been the subject of many recent studies After 
dnnking regular coffee changes of blood pressure 
heart rate and plasma catecholamines have been 
reported (Smits et al , 1983, Whitsett et al , 
1984) It is generally accepted that caffeine is the 
most important pharmacological compound with 
respect to the circulatory effects of drinking 
coffee (Eichler, 1976) Only few studies report 
on the cardiovascular effects of decaffeinated 
coffee Decaffeinated coffee powder has a very 
low caffeine content, approximately 0 05% vs 
1 2-2 0% of regular coffee Dose-response 
studies on the haemodynamic effects of caffeine 
only are available in dose ranges equivalent to 
two to eight cups of coffee (Whitsett et al, 1980) 
but not in the range of low caffeine doses as in 
decaffeinated coffee Therefore we studied 
haemodynamic and humoral variables before 
and after dnnking regular and decaffeinated 
coffee 
Methods 
Six men and six women, all healthy and normo­
tensive, gave their informed consent for this 
study Age, weight, length and quetelet-index 
(mean ± s d ) of these subjects numbered re­
spectively 25 ± 4 7 years, 68 6 ± 11 8 kg, 179 5 
± 6 0 cm and 212 ± 3 3 kg/m2 All persons 
were used to daily coffee intake and mean daily 
coffee consumption vaned from three to 10 cups 
of coffee per day In random sequence, all sub­
jects underwent two single-blind tests, one with 
regular coffee, and one with decaffeinated 
coffee Percolated regular coffee was auto­
matically prepared with 350 ml water and 24 g of 
coffee resulting in two cups of coffee containing 
together about 280 mg caffeine Decaffeinated 
coffee was prepared in the same way The sub­
jects were asked to abstain from caffeine for 17 h 
and from smoking for 4 h before the start of each 
test After arrival at the laboratory a supine rest 
penod of 20 mm started, and in the next 20 mm 
systolic and diastolic blood pressure (SBP and 
DBP by artenosonde 1225), heart rate (HR by 
ECG) and forearm blood flow (FBF by venous 
occlusion plethysmography) were measured each 
5 mm In eight out of 12 subjects blood was 
sampled for humoral parameters Afterwards 
the subjects were asked to drink the coffee 
within lOmin At 90 mm after the start of the test 
the same penods of rest and measurements were 
repeated Plasma caffeine concentrations were 
measured with a reversed phase h ρ 1 с method 
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Plasma catecholamines were determined by a 
radioenzymatic assay and PRA by a radio­
immunoassay All individual haemodynamic 
measurements were averaged to one mean value 
respectively before and after the beverage in­
gestion Haemodynamic and humoral results 
were analysed by respectively Student's f-tcst 
and Wilcoxon test for paired observations All 
results are presented as mean ± s e mean 
Results 
Figure 1 shows the mean values of BP, HR and 
FBF before and after use of coffee and de­
caffeinated coffee Basal BP in the coffee and 
decaffeinated coffee test was not significantly 
Coffee Decaffeinated 
b a coffee 
Figure 1 Blood pressure (BP), heart rate (HR) and 
forearm blood flow (FBF) before (b) and after (a) the 
use of regular and decaffeinated coffee (mean ± s e 
mean of 12 subjects) 'P < 0 05, **/» < 0 01, 
***/> < 0 001, NS not significant 
different measuring respectively 116 ± 3 1/73 ± 
2 4 mm Hg and 115 ± 3 0/70 ± 2 2 mm Hg 
Mean basal HR also was similar m both tests (60 
± 2 2 beats/mm and 62 ± 1 8 beats/mm respec­
tively) After coffee there was a significant rise 
of SBP and DBP of 4 4 ± 1 4% and 11 8 ± 
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2 5% and HR decreased with 8 4 ± 3 1% After 
decaffeinated coffee SBP and HR did not alter 
significantly, but DBP showed a rise of 4 ± 1 4 
mm Hg The coffee induced rise of DBP was 
significantly higher than the increase of DBP 
after decaffeinated coffee (P < 0 05) In both 
tests mean FBF remained unchanged 
Table 1 summanzes the responses of all 
humoral variables to the dnnking of regular and 
decaffeinated coffee Basal values of these para­
meters were the same in both tests In contra­
distinction to the drinking of decaffeinated 
coffee, regular coffee gave a significant rise of 
plasma caffeine concentration Table 1 shows 
that the coffee induced rises of plasma catechol­
amines were significantly higher than the changes 
after decaffeinated coffee In both tests PRA 
showed an insignificant fall after the beverage 
ingestion 
Discussion 
The relation between caffeine ingestion and 
blood pressure gains interest from pharma­
cologists as well as epidemiologists Epidemio­
logical studies report a positive association 
between blood pressure and coffee consumption 
(Lang el al , 1983) In other studies correlations 
were analysed between coffee ingestion and 
morbidity or mortality from coronary heart 
disease, and most of them observed no significant 
association (Dawber el al , 1974) In pharmaco­
logical studies there is also evidence for a positive 
association between blood pressure and caffeine 
intake (Smitsefa/ , 1983, Whitsett et al , 1984) 
Other studies, however, suggested that after 
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PRA showed no alteration These results are in 
close agreement with a previous report (Smits et 
at , 1983) In our tests decaffeinated coffee had 
no influence on humoral parameters In spite of 
the small caffeine content of decaffeinated coffee 
mean plasma caffeine concentration did not nse 
significantly 
From this study wc conclude that drinking 
regular coffee results in a rise of BP, a fall of HR 
and an increase of plasma catecholamines De­
caffeinated coffee only induces a slight increase 
of DBP, and so the circulatory effects of regular 
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CHAPTER III 
(American Journal of Cardiology 19Θ5; 56: 958-963) 
Circulatory Effects of Coffee in Relation 
to the Pharmacokinetics of Caffeine 
PAUL SMITS, MD, THEO TUIEN, MD, and ALBERT vanì LAAR, MD 
Drinking coffee results In an Increase In blood 
pressure (BP) after an Interval of caffeine absti-
nence. During chronic caffeine Intake this pressor 
response disappears and adaptation to the circu-
latory effects of caffeine develops. This study was 
designed lo determine whether a pressor response 
to coffee occurs during chronic caffeine Intake If low 
basal plasma caffeine levels are achieved by a 
period of caffeine abstinence, defined by Individual 
plasma caffeine half-life. In 8 normotenslve subjects, 
circulatory measurements were studied after In-
gestion of coffee In 2 strengths, decaffeinated cof-
fee and hot water after a caffeine abstinence of 4.5 
times Individual caffeine half-life. These measure-
ments were compared to the same protocol without 
Because caffeine and coffee are widely consumed 
throughout the world, a relation between coffee and 
blood pressure (BP) would be of clinical interest ' 2 
Recent studies have reported a positive association 
between BP and coffee consumption ' * There is also 
pharmacologic evidence for a BP-increasing effect of 
caffeine and coffee ^ 7 The relevance of these observa-
tions to the effect of daily coffee use on BP was ques 
tioned by some investigators 8 9 According to these 
studies complete adaptation or tolerance to the circu-
latory effects of caffeine develops during chronic caf-
feine use However, in 1 study there was evidence that 
cardiovascular reactivity to caffeine was greater in 
subjects with initial caffeine levels of less than 1 mg/liter 
than for those with basal plasma caffeine levels of more 
than 1 mg/liter β This means that the development of 
tolerance to the effects of coffee depends on poor caf­
feine use and on the individual pharmacokinetics of 
caffeine In healthy subjects, elimination half-life (ТУг) 
From the Division of General Internal Medicine Department of Medi­
cine University of Nijmegen Nijmegen The Netherlands Manuscript 
received March 11 1985 revised manuscript received May 23 1985, 
accepted May 28 1985 
Address lor reprints ТЪео Thten MD Department of Medicine Di­
vision of General Internal Medicine. Geert Grooteplein ZiM β Ρ О Во« 
9101, 6500 HB Nijmegen The Netherlands 
Intervention. Coffee of both strengths resulted In a 
similar increase In BP (diastolic BP ± 15%). The 
coffee-induced Increase in forearm blood flow and 
plasma epinephrine levels were less pronounced. 
Decaffeinated coffee Inducefl a smaller Increase of 
diastolic BP, and after water, no changes were 
observed. Additionally, a negative correlation was 
found between the coffee-Induced BP Increase and 
basal plasma caffeine level In a group of 30 nor­
motenslve subjects (r = —0.71, ρ <0.001). During 
chronic caffeine Intake, subjects with short plasma 
caffeine half-life are exposed to a pressor response 
after drinking coffee, despite the phenomenon of 
adaptation. 
(Am J Cardkri 1985:56:958-963) 
of plasma caffeine vanes between 1 5 and 9 5 boms1 0 
To determine whether coffee increases BP during 
chronic caffeine ingestion, the time of caffeine absti­
nence before the test must be related to individual 
pharmacokinetics of caffeine. We studied the circula­
tory effects of drinking coffee after a period of caffeine 
abstinence related to individual plasma caffeine Т'/г in 
8 normotensive subjects Hemodynamic and humoral 
effects of 2 strengths of coffee, and of equal amounts of 
decaffeinated coffee and water of the same temperature 
were compared to a similar protocol without interven­
tion In 30 other normotensive subjects, we analyzed 
the relation between basal plasma caffeine level and the 
coffee-induced increase m BP 
Methods 
Eight normotensive, healthy subjects (5 men, 3 women) 
gave informed consent for this study, which was approved by 
the hospital ethical committee The mean age was 23 4 years 
(range 21 to 25), height 180 4 cm (range 169 to 201) and 
Quetelet index 215 kg/m2 (range 17 9 to 24) All subjects were 
accustomed to dally coffee ingestion, and mean estimated 
coffee use ranged from 4 to 9 cups/day Three men were 
habitual smokers and all women used oral contraceptive 
drugs 
The first part of the study was a pharmacokinetic analysis 
of all subjects Before and after drinking 2 cups of coffee, blood 
21 
samples were drawn for determination of plasma caffeine 
concentration After coffee ingestion, blood was sampled ever> 
20 minutes for 2 hours, and afterward another 3 times dis 
tnbuted over about 20 hours From these data, time of plasma 
peak level (Tm) was registered and the elimination caffeine 
Т г was calculated As Τ Vi and Tm do not differ within an 
individual after different doses of oral caffeine, a single 
measurement of these values was sufficient10 
After this pilot study every subject took part in 5 tests, 
which were ordered at random and separated from each other 
by at least 1 week All tests had the same protocol, different 
only in the kind of intervention similar amounts of regular 
coffee, stronger coffee, decaffeinated coffee, hot water and ' no 
intervention " For the tests with regular, strong and decaf 
feinated coffee the protocol was single blind, but as a matter 
of course this could not be realized for the tests with hot water 
and no intervention Before all tests were performed, the 
subjects had to abstain from all caffeine containing products 
for a period of 4 5 half lives At the beginning of this period 
200 mg of caffeine were ingested (as tablets) to be sure that 
abstinence was not longer than 4 5 half lives The subjects 
were not allowed to smoke for θ hours before the tests and 
a light caffeine free breakfast was allowed between 7 30 and 
8 00ΛΜ 
All tests were performed from 8 15 to 11 15 AM with the 
subject in the supine position The first 30 minutes served as 
an equilibration period to reach basal hemodynamic and hu 
moral values In this period an Artenosonde 1225 (semiau 
tomatic BP monitor) and a mercury strain gauge venous oc 
elusion Plethysmograph (forearm blood flow registration) were 
connected to the subject's left arm Because we only wanted 
to measure muscle flow, a wrist cuff was inflated during the 
measurements to block the skin flow of the hand Heart rate 
was measured by electrocardiogram An antecubital vein of 
the right arm was cannulated and blood samples were taken 
for determination of plasma caffeine renin and norepineph 
rine concentrations just before intervention, at the individ 
ual Tm and 120 minutes after intervention After the first 30 
minutes of equilibration, systolic and diastolic BP and heart 
rate were measured every 5 minutes for 30 minutes In be­
tween these measurements 4 series of 3 forearm blood flow 
recordings were made and blood was sampled Subsequently 
the subjects had to drink 300 ml of a beverage within 10 
minutes in the supine position with the aid of a straw (except 
in the no intervention test) All beverages were prepared using 
a coffee machine with 100 ml »f water and depending on the 
test, 25 g of coffee (strong coffee) 17 5 g of coffee (regular 
coffee), 17 5 g of decaffeinated coffee and no coffee (hot water 
test) Then, systolic and diastolic BPs and heart rate were 
recorded every 5 minutes for 2 hours, and again a series of 3 
forearm blood flow registrations were made in between The 
protocol of the tests is illustrated in Figure 1 
In 10 other normotensive and healthy subjects we also 
studied the hemodynamic effects of coffee The same protocol 
as in the regular coffee test was used For these subjects, 
however, the time of caffeine abstinence was arbitrary and not 
related to plasma caffeine ТУг We used this group to study 
the relation between basal plasma caffeine levels and pressor 
responses to coffee In these subjects we did not sample blood 
for determination of plasma catecholamines or plasma renin 
activity 
Plasma concentrations of caffeine were analyzed with a 
reversed phase high performance liquid chromatography 
method G Plasma catecholamine levels were measured by a 
radioenzvmatic assay,11 and plasma renin activity by radio 
immunoassay 1 2 
Statistical analysis Hemodynamic variables betöre in 
tervention were averaged for each subject to 1 basic value, and 
after intervention to 1 value for every period of 20 minutes 
Differences between the 20 minute period values and the 
basic value were averaged for each subject, resulting in 1 mean 
change over the 2 hour period In the statistical analysis these 
mean changes induced by strong, regular or decaffeinated 
coffee or hot water were compared with the results of the no-
intervention test by Student t test for paired observations 
(2 sided) Humoral variables were analyzed by comparing 
values after intervention with basal values by the paired 
Wilcoxon test (2 sided) The fractional changes in the 5 tests 
also were compared with each other Correlation coefficients 
were calculated according to Pearson Mean arterial pressure 
was calculated as the sum of diastolic BP and one third of 
pulse pressure, and forearm vascular resistance was calculated 
by dividing mean arterial pressure through forearm blood 
flow Forearm vascular resistance is expressed in arbitrary 
units All results are presented as mean ± standard error of 
the mean 
Results 
The results of the preliminary pharmacokinetic 
measurements are shown in Figure 2 Peak plasma 
caffeine concentrations were reached in 4 subjects in the 
first, m 1 in the third, in 2 in the fourth and in 1 in the 
fifth 20 minute period after coffee The mean Tm was 
50 ± 12 minutes Calculated ТУг ranged from 2 to θ 5 
hours (mean 4 2 ± 0 8) The caffeine abstinence period 
for the 5 tests ranged from 9 to 381/4 hours In the pilot 
study the mean peak plasma caffeine level was 4 3 ± 0 6 
mg/liter Figure 2 shows that plasma caffeine levels are 
almost in a steady state during the tests 
E /NE l η m e l / l I 0 08/107 016/119 017/121 
PRA i n g / m l hr ) Ι 5β 1 « I O 
C f (mg/I ) 0 Í 6 6 6) 
Te ' t n ' T 1 3 
g 30 ig 00 |00 
Τ m i 
FIGURE 1 Schedule of measurements m 8 subjects after drinking 
strong coffee Mean values ( ± standard error of the mean) of blood 
pressure (BP) heart rate (HR) and forearm blood flow (FBF) before and 
for б periods of 20 minutes after coffee ingestion are given Plasma 
concentrations of norepinephrine epinephrine (NE E) renin (PRA) 
and caffeine (cf) were measured 3 times T m = time of plasma peak 
level 
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TABLE I Basal Values of all Hemodynamic Parameters in Ihe Five Tests 
Systolic blood pressure 
(mmHg) 
Diastolic blood pressure 
(mmHg) 
Mean arterial pressure 
(mmHg) 
Heart rale (beats/mln) 
Forearm blood flow 
(ml/100 ml-mln) 
Forearm vascular 
resistance (U) 
N1 
1 1 0 ± 2 
72 ± 2 
85 ± 2 
72 ± 3 
2 5 І 0 2 
37 ± 4 
W 
111 ± 2 
6 β ± 3 
83 ± 2 
73 ± 3 
2 7 І 0 3 
34 ± 5 
DC 
113± 2 
67 ± 2 
82 ± 2 
72 ± 3 
2 7 ± 0 3 
34 ± 4 
RC 
110± 2 
66 ± 3 
81 ± 2 
73 ± 3 
2 6 ± 0 3 
3 6 ± 6 
SC 
108 ± 1 
66 ± 2 
81 ± 2 
68 ± 2 
2 3 ± 0 3 
4 0 ± 6 
All values are mean ± standard error of the mean 
DC = decaffeinated coffee, N1 - no Intervention, RC » regular coffee, SC - strong coffee, W = 
water 
In Table I all basal hemodynamic data of the 5 tests 
are listed, and these values revealed no statistically 
significant differences. Mean changes over the 2-hour 
period of systolic and diastolic BPs, heart rate and 
forearm blood flow in the 5 experimental situations are 
shown m Figure 3. In the regular and strong coffee tests, 
the systolic BP increase measured 4 ± 1 and 5 ± 2 mm 
Hg, respectively; these increases were significantly 
higher than those in the other tests. The same applied 
to the increases in diastolic BP of 8 ± 1 and 9 ± 1 mm 
Hg, respectively, and in mean arterial pressure of 7 ± 1 
mm Hg in both tests. Figure 4 shows that the increase 
in BP was maximal in the last hour. In the regular and 
strong coffee tests, the percent increase in diastolic BP 
in the last 20-minute period was 16 ± 3% and 15 ± 4%, 
respectively. After ingestion of regular coffee, the indi­
vidual maximal increase in mean arterial pressure 
ranged from 8 to 19% and after strong coffee from 8 to 
15%. There was no relation between the individual 
increase in mean arterial pressure and the correspond­
ing time of caffeine abstinence. After ingestion of de­
caffeinated coffee, a smaller increase in diastolic BP 
was observed, whereas drinking water did not induce 
any changes. In all tests a decrease in heart rate was 
observed, and after water, regular coffee and strong 
coffee, these decreases were greater than those after 
the no-intervention test (p <0.10); they were 5 ± 1,7 ± 
2 and 5 ± 1 beats/min, respectively. Without interven­
tion, mean heart rate decreased by 2 ± 1 beats/min 
(Fig. 3). There was a significant difference between the 
increase in forearm blood flow of 0.3 ± 0.2 ml/100 
ml-min after strong coffee intake and the decrease of 
0.2 ± 0.2 ml/100 ml-min during the water and decaf­
feinated coffee test. As a consequence mean forearm 
vascular resistance decreased 2.1 ± 2.8 U during the 
strong coffee test, which was different from the in­
crease in forearm vascular resistance of 3.6 ± 2.1 and 
3.5 ± 2.1 U after hot water and decaffeinated coffee 
(p - 0.03, ρ = 0.07). 
Figure 5 shows all humoral measurements of the 5 
tests. Individual basal plasma caffeine levels of these 
tests were all within the range of less than 0.1 to 2.0 
mg/hter, independent of the time of caffeine abstinence 
(n = 40, г = -0.25, ρ >0.1). After ingestion of strong and 
regular coffee, a significant increase in plasma caffeine 
levels to 6.6 ± 0.4 and 5.2 ± 0.9 mg/liter was observed, 
the former being significantly greater than the latter (p 
<0.005). In the hot-water and no-intervention tests, 
plasma caffeine concentration showed a small but sig­
nificant decrease of 0.2 mg/liter at the end of the tests; 
caligine l m g / l ) 
FIGURE 2. Course of plasma caffeine levels In subjects after 
drinking coffee Mean results (± standard error of the mean) 
as well as the results of the subjects with the shorlest and 
longest elimination half-life (tVz) of caffeine are given. 
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after decaffeinated coffee was ingested, no significant 
change was observed. Table II lists the mean fractional 
changes of plasma catecholamine levels. Changes in 
plasma norepinephrine levels were about the same 
among the 5 tests. Plasma epinephrine levels, however, 
increased more significantly after consumption of reg­
ular and strong coffee than after decaffeinated coffee. 
Plasma epinephrine levels and plasma renin activity 
were significantly different during all tests compared 
with basal values. The percent reduction of plas­
ma renin activity after drinking decaffeinated coffee 
(-17 ± 7%), regular coffee (-19 ± 7%) and strong cof­
fee (-18 ± 5%) was smaller than after drinking hot 
water (-33 ± 5%, ρ < 0.10). In the 4 tests in which a 
beverage was ingested, there was a significant correla­
tion between the increase in plasma caffeine and the 
fractional increase in mean arterial pressure (n = 32, г 
= 0.70, ρ <0.001). The fractional increase in plasma 
epinephrine weakly correlated with changes of plasma 
caffeine (n = 32, г » 0.36, ρ <0.05). 
Figure 6 shows the most relevant results of the second 
part of the study. In the 30 subjects, a strong correlation 
was observed between basal caffeine level and the in­
crease in mean arterial pressure in the second hour after 
drinking coffee (10log (caffeine) vs mean arterial pres­
sure: η = 30, г = -0.71, ρ <0.001). Mean increase in 
mean arterial pressure measured 7 ± 1% (range -1 to 
24%). Because of the arbitrary time of caffeine ab­
stinence, there was also a large range of basal plasma 
caffeine levels (less than 0.1 to 6.3 mg/liter, mean 
1.0 ± 0.3). 
Discussion 
Under experimental conditions there is clear evidence 
for a BP-increasing effect of caffeine,6 ^ 1 3 · 1 4 but dur­
ing chronic ingestion of caffeine no cardiovascular re­
sponse to caffeine or coffee occurred.''9 In 1968, Colton 
et al16 suggested that this tolerance could partly ei-
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FIGURE 3. Mean changes over the 2-hour period of systolic and diastolic 
blood pressire (SBP, DBP). heart rate (НИ) and forearm blood flow (FBF) 
after no intervention (N1), consumption of water (W), decaffeinated 
coffee (DC), regular coffee (RC) and strong coffee (SC) (mean ± 
standard error of the mean) A*1*rl*kt represent significances with 
respect to no intervention, unless signed otherwise bpm = beats/ 
min. NS = not significant, · ρ < 0 10. · ρ < 0 05. " p < 0 0 1 , * ' " ρ 
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Δ m«an arterial pressure ΓΑ 
no inter vtrtion 
FIGURE 4. Fractional changes of mean arterial pressure 
for every 20-minute period after no intervention and after 
consumption of regular and strong coffee (mean ± stan­
dard error of the mean) 
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TABLE II Mean Changes In Plasma Catecholamines In the Five Tests 
Epinephrine (%) 
Norepinephrine (%) 
75 ± 3 3 
- 2 ± 5 
61 ± 4 1 
6 ± 11 
33 ± 10 
4 ± 8 
ВС 
β θ ± 14* 
7 ± β 
140 ± 47* 
14 ± 10 
• ρ <0 05 vs decaffeinaled coffee tesi 
All values are mean ± standanl βποτ of the mean. 
Abbreviations as in Table I 
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FIGURE 5. Mean (± standard error of the mean) values (n - 8) of 
plasma concentrations of norepinephrine (NE. E), renin (PRA) and 
calfelne (cf) before, at plasma peak level (Tm) and 120 minutes after 
no Intervention (NI), consumption of water (W), decaffeinated coffee 
(DC), regular coffee (RC) and strong coffee (SC) Aeterltk« represent 
significances with respect to basal values NS * not significant; * ρ 
<0 05. · · ρ <0.01·. ' · · ρ < 0 001 
plain contradictory observations reported with re­
spect to the circulatory effects of caffeine. The evi­
dent disparity between the acute effects of caffeine 
and the results of epidemiologic studies, which show 
no association between coffee and coronary heart 
disease,16-18 also has been explained by the phenome­
non of tolerance.8 
In this study we could affirm the presumption that 
BP increase after consumption of coffee depends on 
basal plasma caffeine concentration (Fig. 6). Further, 
the problem has been evaluated from another point of 
view by testing the hypothesis, that a significant BP 
increase will occur when abstinence of caffeine is long 
enough to reach low basal plasma caffeine levels. In this 
study we used a caffeine abstinence of 4.5 half-lives, and 
such periods of abstinence are likely to occur in daily 
life. The range of half-lives from 2 to 8.5 hours in our 
subjects is in close agreement with other observations,10 
and this wide range is brought about by several exogenic 
influences,19·20-22 as well as by genetically determined 
interindividual differences.23 Despite a significant 
difference between the increase in plasma caffeine levels 
after ingestion of regular and strong coffee, the re­
sponses of BP were similar (Fig. 4). These results agree 
with the observation of a flat dose-response curve with 
respect to the BP-increasing effect of drinking 2 to 8 
cups of coffee.24 The observed BP increase after coffee 
ingestion did not show any correlation with the duration 
of caffeine abstinence. Consequently, we conclude that 
drinking coffee leads to an increase in BP after caffeine 
abstinence for 4.5 half-lives. In a previous study, plasma 
caffeine levels were measured in 600 consecutive pa­
tients; in about 50% of this group, plasma caffeine 
ûmeanartenal pressure (*/·) 
?i 0 - , · 
20 0 -
16 0 
12 0 
8 0 -
FIOURE β. The relation between basal plasma caffeine 
concentration and the fractional Increase In mean arterial 
pressure In the second hour after consumption of coffee In 
30 normotenstve subjects (Δ mean arterial pressure vs 
'"log [caffeine)) 
SO 10 0 
catleme (mg/l ) 
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concentration was less than 2.0 mg/liter.25 This indi­
cates that drinking coffee may induce an increase in BP 
in daily life in a considerable proportion of the popu­
lation. Drinking decaffeinated coffee induced only a 
small increase in diastolic BP, an observation that 
agrees with reported data.'26 
In another study, stronger BP increases are reported 
after a comparable load of coffee drinking.6 However, 
in that study caffeine abstinence was longer, also re­
flected by a lower mean basal plasma caffeine of 0.3 
mg/liter. Probably, the lower BP response to coffee in 
this study can be traced to partial tolerance, which 
would disappear after longer caffeine abstinence. The 
complete tolerance in Robertson's study,8 even after 15 
hours of caffeine abstinence, can be explained by the 
extremely long mean ТУг (10 hours) of his subjects, re­
sulting in a mean basal plasma caffeine of 2.3 mg/liter. 
Ammon et al9 also observed complete tolerance to cof­
fee, but no plasma caffeine data were available. 
Epidemiologic studies have related mean coffee 
consumption to BP. Because of the results of this study, 
we believe a more valid conclusion could be drawn if the 
pharmacokinetics of caffeine were taken into consid­
eration. Additionally, epidemiologists always correct 
for cigarette smoking because smoking is an indepen­
dent risk factor in coronary heart disease and because 
coffee consumption and cigarette smoking are strongly 
related habits.16 Because mean Т г of caffeine is shorter 
in people who smoke,19 our results indicate that such a 
correction could lead to underestimation of the rela­
tion between BP or coronary heart disease and coffee. 
Decreases in heart rate did not reveal clear significant 
differences between the 5 tests and, therefore, an ad 
ditional effect of caffeine on the decrease in heart rate 
could not be proved with these observations, in contrast 
to other reports.5·26 The changes in forearm blood flow 
and forearm vascular resistance illustrate that drinking 
strong coffee induces a slight vasodilation in the forearm 
muscle when compared with beverages containing no 
or a very small amount of caffeine. These data are not 
conclusive with respect to the effect of coffee on to­
tal peripheral resistance, because caffeine could in­
duce opposite effects in blood vessels of other organ 
systems. 
Changes of plasma epinephrine after consumption 
of coffee were less striking than in former reports.6·26 
This also may be explained by partial tolerance to the 
effects of coffee. The decrease in plasma renin activity 
in all tests, including the no-intervention test, suggests 
that this could be the result of the circadian rhythm of 
plasma renin activity, because all tests were performed 
in the morning.27 
From this study we conclude that drinking coffee 
results in an increase in BP and a possible vasodilation 
in forearm muscle. Plasma epinephrine levels tend to 
increase after coffee, whereas plasma norepinephrine 
and renin activity do not change. There are no differ­
ences when drinking regular or stronger coffee. Drinking 
water does not result in circulatory changes, whereas 
drinking decaffeinated coffee induces a small increase 
in diastolic BP when compared with no intervention. 
Relevant hemodynamic changes with coffee already 
occur after caffeine abstinence of 4.5 half-lives. In nor-
motensive subjects there is a strong negative correlation 
between the coffee-induced BP increase and basal 
plasma caffeine concentration. The Т'/г of caffeine 
shows a large variation, and subjects with short T1/) are 
definitely exposed to pressor responses to coffee, de­
pending on their daily intake. 
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CHAPTER IV 
(Clinical Pharmacology & Therapeutics 1983; 34: 153-158) 
Hemodynamic and humoral effects of coffee after /3i-selective 
and nonselective /3-blockade 
Several studies report a substantial rise in plasma catecholamines after caffeine. Epinephrine 
infusion induces a pressor response after nonselective ß-blockade. We studied the hemodynamic 
and humoral effects of drinking coffee after placebo and after both nonselective (propranolol) 
and β,-selective (meloprolol) blockade m 12 normotensive subjects After placebo, coffee 
indue ed a rise in systolic and diastolic blood pressure and a fall in heart rate, whereas forearm 
blood flow did not change Plasma catecholamines, especially epinephrine ( + 150%), rose and 
plasma renin activity, fell after drinking coffee The effects of coffee on blood pressure, forearm 
blood flow, and all humoral parameters were not altered by pretreatment with propranolol or 
meloprolol The fall in heart rate after coffee, however, seemed to be greater during 
propranolol. We conclude that the rise in plasma epinephrine after coffee was too small to 
re\ eal differences m reaction m propranolol- and metoprolol-pretreated subjects 
Paul Smits, M.O., Hans Hoffmann, M.Sc., Theo Thlen, M.D., Harry Houben, M.D., 
and Albert van 't Laar, M.D. Nijmegen, The Netherlands 
Division of General Internal Medicine, Department of Medicine, and Department of Chemical 
and Experimental Endocrinology, University of Nijmegen 
an increase in total peripheral resistance, which 
is responsible for the pressor response. Possible 
spontaneously occurring examples of this phe­
nomenon have been reported.2·21·24 The clinical 
relevance, however, has not been fully eluci­
dated. Until now, it has not been proved that 
stresses of daily life can also result in a pressor 
response during treatment with propranolol. 
Since caffeine results in an increase in plasma 
catecholamines,25·26·27 drinking coffee can be 
considered as such a stress. Our aim was to find 
out whether drinking coffee results in different 
hemodynamic effects after pretreatment with 
propranolol and meloprolol. 
Methods 
Our subjects were nine male and three female-
volunteers, ranging in age from 17 to 38 yr, 
27 
In other reports from our department, hemo­
dynamic effects of epinephrine infusions after 
pretreatment with /3,-selective and nonselec­
tive /3-adrenergic blockade have been re­
ported. i e · 1 8 · 1 9 After meloprolol, the normal va­
sodilation after epinephrine was largely main­
tained, whereas after propranolol, there was a 
vasoconstrictive or pressor response. This 
pressor response could be explained by the 
blockade of /^-adrenergic receptors by pro­
pranolol, leaving the α-adrenergic vasocon­
striction caused by epinephrine unopposed. 
This so-called "unopposed α-effect" results in 
Received for publication Oct 22, 1982, accepted Dec 21, 1982 
Reprint requests to Dr Theo Thien, Department of Medicine, 
Division of General Internal Medicine, Geert Gtooteplein Zuid 8, 
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who were normotensive and otherwise healthy 
All were habitual coffee drinkers (mean = 4 5, 
range two to eight cups of coffee a day) 
Lengths and body weights (mean ± SD) of the 
subjects amounted to 182 5 ± 10 0 cm and 
72 7 ± 12 1 kg 
Each subject participated in three tests in ran­
dom order in which they received two cups of 
coffee after placebo, 240 mg propranolol, and 
300 mg metoprolol These doses were given in 
a double-blind manner and were split up in three 
tablets, taken 15, 9, and 1 hr before starting 
each test The three tests were separated from 
each other by at least 3 days Before each test, 
the subjects had to abstain from caffeine-
containing products for at least 17 hr and from 
smoking for 10 hr 
After am val at the laboratory, the subjects 
rested for 20 min in a supine position This 
penod of rest started with the insertion of a 
catheter in an antecubital vein of the left arm 
This was followed by the connection of the Ar-
tenosonde and the Plethysmograph to the sub­
jects' right ami, which was placed in an arm 
support 5 to 10 cm above heart level After this 
initial period, five determinations of blood pres­
sure (BP) and heart rate (HR) were made every 
5 mm After the first measurement, blood was 
drawn to determine blood levels of caffeine, 
plasma renin activity (PRA), and catechol­
amines Between the following four measure­
ments, three senes of five forearm blood flow 
(FBF) determinations were made After that, 
the subjects were asked to dnnk two cups of cof­
fee within 10 mm Forty minutes later, exactly 
the same periods of rest and measurements were 
repeated The protocol is illustrated in Fig I by 
an example of a coffee test after propranolol 
Coffee was prepared according to a standard­
ized method with 350 ml water and 24 gm cof­
fee This resulted in two cups of coffee, each 
containing 150 ml BP was measured with the 
Artenosonde 1225, and HR was calculated 
from an ECG registration FBF was measured 
with a mercury strain-gauge venous occlusion 
Plethysmograph Since we wanted to measure 
only changes in muscle FBF, room temperature 
was kept between 19° and 20 5° ' 
Samples for determination of plasma caffeine 
were analyzed with a reversed-phase HPLC 
method For this determination, a Spectra 
Physics 3500 В machine was used The column 
(stainless steel, length 15 cm, internal diameter 
4 6 mm) was packed with Lichrosorb RP8, 5-μ 
particle size Detection was affected at 270 nm 
with a UV detector, model SP770 An injection 
loop of 100 μΐ was used The solvent was a 
mixture of 0 02M sodium acetate and 20% 
methanol Solvent flow measured 1 2 ml/mm 
The sample was prepared by mixing 100 μ.1 
plasma with 400 μ\ perchloric acid, 0 23N The 
mixture was centnfuged, and 100 μΐ of the clear 
supernatant was injected onto the column 
Catecholamines were measured by a radioen-
zymatic assay17 and PRA by a radioimmunoas­
say 7 In seven subjects, plasma concentration of 
propranolol and metoprolol were determined by 
a gas chromatographic method 9 
The hemodynamic and humoral effects of 
coffee after propranolol and metoprolol were 
compared with each other and with the results 
of the placebo test For each subject, all mea­
surements of BP, HR, and FBF were averaged 
both before and after coffee Student's t test for 
paired observations was used Mean arterial 
pressure (MAP) was calculated as the sum of 
diastolic blood pressure (DBP) and one third 
of pulse pressure Forearm vascular resistance 
(FVR) was calculated by dividing MAP through 
FBF and expressed in arbitrary units All results 
are presented as mean ± SE 
Results 
Fig 2 shows the values of BP, HR, and FBF 
before and after use of coffee in the placebo, 
propranolol, and metoprolol tests Mean basal 
values of BP and HR after placebo measured 
116/69 ± 2/2 mm Hg and 63 ± 3 bpm Both 
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Fig. 1. BP. HR, and FBF before and after coffee in 
one subject after pretreatment with propranolol. Val-
ues of FBF are all mean ± SE of five determinations. 
At the time indicated by the arrows, blood was sam-
pled for humoral parameters. 
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Fig. 2. BP, HR, and FBF before (b) and after (a) the 
coffee in placebo, propranolol, and metoprolol tests 
(mean ± SE). *P < 0 05, **P < 0.01, ***P < 
0.001. ns = not significant. 
/3-blockers reduced BP and HR. After proprano­
lol and metoprolol, basal BP amounted to 108/ 
65 ± 2/1 mm Hg and 108/64 ± 1/1 mm Hg, 
and HR was 56 ± 1 and 54 ± 1 bpm. 
Drinking coffee induced a rise in BP and a 
fall in HR. The mean percent rise in systolic 
blood pressure (SBP) after coffee during the 
placebo, propranolol, and metoprolol test was 
4%, 7%, and 7%,- those in DBP were 16%, 
22%, and 19%. The elevations were all sig­
nificant but did not differ significantly from 
each other. After coffee, HR fell in all three 
tests. The fall in HR of 7 bpm after propranolol 
was greater than the fall of 4 bpm in both other 
tests. Table I shows mean values of the changes 
in BP and HR after coffee in the three tests. 
Basal FBF after placebo, propranolol, and 
metoprolol amounted to 3.1 ± 0.4, 2.8 ± 0.3, 
and 3.0 ± 0.5 ml/100 ml · min, and after cof­
fee these values were not significantly less: 
2.9 ± 0.3, 2.4 ± 0.2, and 2.3 ± 0.2. Calcu­
lated FVR rose from 31 ± 2.9 to 38 ± 4.6 U 
in the placebo test, after propranolol from 
31 ± 3.5 to 42 ± 4.0 U, and after metoprolol 
from 32 ± 4.0 to 41 ± 3.5 U. Only in the 
propranolol test did the elevation in FVR reach 
statistical significance. 
Mean basal plasma concentrations of caffeine 
were identical in all three tests and amounted to 
0.3 μg/ml (range: <0.2 to 1.0 μg/ml). Sixty 
minutes after the coffee, mean concentrations 
rose to 8.2 ± 0.8, 7.8 ± 0.5, and 7.9 ± 0.6 
μg/ml in the placebo, propranolol, and meto­
prolol tests (range: 4.9 to 14.1 μg/ml). 
The basal PR A after propranolol (1.49 ± 
0.36 ng/ml · hr"1) was lower than after 
placebo (2.43 ± 0.50 ng/ml • hr 1), whereas 
basal PRA after metoprolol (1.87 ± 0.51 ng/ 
ml · hr-1) was not significantly lower. In all 
tests, coffee induced a fall in PRA to 1.75 ± 
0.24 (placebo), 0.99 ± 0.25 (propranolol), and 
1 ± 0.18 ng/ml · h r ' (metoprolol). 
Basal plasma epinephrine and norepinephrine 
were highest after metoprolol and lowest after 
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Table I. Changes (λ) m SBP. DBP, MAP, and HR because of coffee after placebo, 
propranolol, and metoprolol (mean ± SE) 
Placebo PI Propranolol P2 Metoprolol P3 
Λ SBP (mm Hg) 
Λ DBP (mm Hg) 
Λ ΜΛΡ (mm Hg) 
Λ HR (beats/mm) 
5 
II 
9 
-4 
I 4 
2 0 
I 4 
I 4 
NS 
NS 
NS 
Ρ < 005 
7 ± 1 2 
14 ± 1 2 
11 ± I 2 
-7 ± 09 
NS 
NS 
NS 
= 0 08 
8 
12 
II 
- 4 : 
1 2 
1 4 
1 2 
1 4 
NS 
NS 
NS 
NS 
P] - placebo vs propranolol P2 - propranolol vs meioprolol РЭ - mecoprolol vs placebo NS noi sigmfìcanl 
Table II. Plasma levels of epinephrine and norepinephrine before and after use of coffee m 
placebo, propranolol, and metoprolol tests (mean ± SE) 
Placebo 
Before After 
Propranolol 
Before After 
Metoprolol 
Before After 
E (nmol/l) 
Nb(nmol/l) 
0 15 
1 55 
001 
0 18 
* 0 37 ± 0 08 
t I 85 ± 0 18 
0 17 ± 0 02 *0 43 ± 0 09 
1 75 ± 0 16 Í 2 12 ± 0 27 
0 21 + 0 04 
1 89 ± 0 37 
t 0 54 
X 2 13 
0 15 
0 27 
fc - epinephnne NE - norepinephnne 
• P i 0 01 tP · 0 02 tn« significanl 
placebo but did not differ significantly from 
each other During placebo, propranolol and 
metoprolol epinephnne rose after coffee drink-
ing 147%, 153%, and 157% The nse in 
plasma norepinephrine after coffee ingestion 
in the placebo test measured only 19% (P < 
0 02) Table II shows all data on plasma cate-
cholamines 
Mean plasma concentrations of propranolol 
and metoprolol determined in seven subjects 
amounted to 289 nmoMl (range 82 to 690 nmol/ 
/) and 703 nmol// (range 330 to 1150 nmol//) 
Discussion 
Caffeine-containing products such as coffee, 
tea, cola-flavored dnnks, cacao, and chocolate 
are widely used Thus pharmacologic effects of 
caffeine and eventual interactions with /3-block-
ade could be of great clinical importance Many 
organ systems, e g , the gastrointestinal tract, 
central nervous system, kidneys, and cardio-
vascular system, are influenced by caffeine * 
Possible pharmacologic mechanisms for the 
cardiovascular effects of caffeine are inhibition 
of the enzyme phosphodiesterase,4 antagonism 
of endogenous adenosine,12 and influence on 
intracellular Ca2+ concentration,8 all of which 
can be desenbed as peripheral direct mecha-
nisms The hemodynamic effects of caffeine 
30 
could be partly based on the increased release of 
catecholamines and on a rise in PRA 2a Besides 
the former direct and the latter indirect penph-
eral mechanisms, central stimulation of vagal 
centers and of the vasomotor center in the brain 
stem could be important mechanisms for the 
cardiovascular effects of caffeine ^ 
The literature on the hemodynamic effects of 
caffeine has many references to an increase in 
gp ii ia 2> л j
n s o r n e ; however, this effect could 
not be affirmed ' ' 2 8 The effects of caffeine on 
HR are also controversial 6 u l 0 2 5 2 9 As far as 
we know, there is no literature available on the 
effects of coffee on FBF After infusion of the 
methylxanthine theophylline, an increase in 
FBF has been observed u A nse in FBF could 
also be expected after coffee as a result of the 
direct relaxing effect of caffeine on smooth 
muscle cells8 and through epinephnne-mediated 
/Зг-гесеріог stimulation In our study, FBF was 
not changed by coffee Differences in expen-
mental design and tolerance to the effects of 
caffeine could be responsible for all the con­
tradictions in the literature on the hemodynamic 
effects of caffeine β " With respect to this toler­
ance, Robertson et a l 2 7 suggested that absti­
nence from caffeine for more than 24 hr was 
required for maximal BP response In our study 
we measured considerable changes in hemody-
namics after an abstinence penod of at least 17 
hr Sixty minutes after coffee, we observed an 
increase in BP and a fall in HR in the placebo 
test After caffeine, a fall in total peripheral 
resistance has been reported 1 , 2 S Since we did 
not observe a fall in FVR in all three tests, 
whereas DBP showed a rise, the latter being 
more pronounced than that in SBP, our results 
indicate that an increase in total peripheral resis­
tance takes place 
In our study the rises in plasma epinephrine 
after coffee always exceeded those in plasma 
norepinephrine Since we are looking for he­
modynamic interactions between propranolol 
and daily life stresses with a nse in plasma epi­
nephrine, coffee seems a suitable stress stimu­
lus for our study Neither basal plasma cate­
cholamines nor the response of catecholamines 
to coffee was changed by pretreatment with 
/3-blockers As could be expected, both pro­
pranolol and metoprolol lowered basal PRA 3 
After coffee, PRA decreased in all three tests 
These observations differ from those in other 
reports,2"' ^ 3 3 all of which reported an increase 
in PRA after methylxanthines Although we do 
not have an explanation for the observed de­
crease in PRA, we can nevertheless conclude 
that it is not likely that, in our study, the effect 
of coffee on BP was mediated by the renin-
angiotensin system 
Single-dose studies with the cardioselective 
^-antagonists atenolol and metoprolol have re­
vealed an acute hypotensive response in nor-
motensive subjects after both drugs 10 2 0 After 
80 mg propranolol by mouth, Thadini and Par­
ker30 noted an acute fall in SBP, but according 
to Buhler," the fall in BP gets through only after 
several days In our study, BP decreased within 
15 hr to identical values after both metoprolol 
and propranolol The wide range of plasma 
concentrations of both /3-blockers is in close 
agreement with other reports22 3 0 and is the re­
sult of the major first-pass removal of these 
drugs by the liver With respect to this, there is 
no evidence for lack of compliance with the 
/3-blocker pretreatment in our study 
With respect to the primary aim of our study, 
we could not distinguish differences in BP re­
sponse to coffee during the three tests Reac­
tions of FBF to coffee were also identical 
throughout the three tests Thus we did not 
show an "unopposed α-effect" after coffee in 
the propranolol test We have studied19 the ef­
fect of low-dose epinephrine infusion on hemo­
dynamics after selective and nonselective ß-
blockade in hypertension At the lowest rate of 
infusion, which corresponded with a nse in 
plasma epinephrine of 200% to 400%, we ob-
served significant differences in reaction in 
propranolol- and metoprolol-treated patients 
Since, in our study, plasma epinephrine rose 
150% to 160% after coffee, the stress stimulus 
used in our study was likely to be too small to 
reveal differences in hemodynamics of the 
propranolol and metoprolol test 
During the propranolol test, the fall in HR 
was stronger than in both other tests This could 
be the result of the quimdine-hke properties of 
propranolol After in vivo and in vitro experi-
ments with rats, Strubelt29 concluded that pro-
pranolol inhibited the positive chronotropic ef-
fect of methylxanthines in rats not only as a 
result of the j3-receptor- blocking properties of 
propranolol but also because of its membrane-
stabilizing activities Since metoprolol has no 
membrane-stabilizing activity, this mechanism 
may have contributed to the greater fall in HR 
after propranolol 
The authors gratefully acknowledge the assistance 
of Miekie Thissen-Jansen and Ita Baars, who per-
formed the plasma renin activity assays and the 
plasma caffeine determinations 
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CHAPTER V 
(European Journal of Clinical Pharmacology 19Θ6; 30: 171-175) 
Influence of Slow Calcium-Channel Blockade 
on the Cardiovascular Effects of Coffee 
P Smits, Τ Thien, and A van 't Laar 
Division of General Internal Medicine, Department of Medicine Umvercity of Nijmegen Nijmegen, The Netherlands 
Summary. An increase in blood pressure after coffee 
and caffeine has recently been reported A possible 
pharmacological mechanism for this pressor re­
sponse is a nse in the intracellular calcium concen­
tration, caused by an increase in calaum influx due 
to a direct effect of caffeine Accordingly, the cardio­
vascular effects of drinking coffee after placebo and 
verapamil 3 χ 80 mg in 1 day in 10 normotensive vol­
unteers have been examined in a single blind study 
After placebo, coffee led to an increase in blood 
pressure (7/14 mm Hg), and a fall in heart rate 
( - 7 beats/min). forearm blood flow did not change 
Plasma epinephrine rose (257%), plasma norepi­
nephrine did not change and the plasma renin activi­
ty fell significantly The haemodynamtc and humoral 
changes after coffee were not altered by pretreatment 
with verapamil It is concluded that increased trans­
membrane calcium influx after caffeine does not ap­
pear to be an important pharmacological mechanism 
for the circulatory effects of coffee 
Key words: caffeine, verapamil, coffee, blood pres­
sure, slow calcium-channel blockade, drug inter­
action, healthy volunteers, plasma catecholamines, 
plasma renin activity 
Since caffeine is frequently ingested, its haemody-
namic effects and possible interactions with antihy­
pertensive agents are of great importance Although 
there are many contradictory reports in the literature 
on the haemodynamic effects of caffeine, recent 
studies have shown an increase in blood pressure af­
ter coffee or caffeine both in normotensive and hy­
pertensive subjects (Freestone and Ramsay 1982, Iz-
zoetal 1983,Smitsetal 1983, Whitsett etal 1984) 
Several pharmacological efTects of caffeine might be 
responsible for the effect (Rail 1980) According to 
Eichler (1976), one of the most important mecha­
nisms for the circulatory efTects of caffeine is a nse in 
the cytoplasmic calcium (Ca) concentration At least 
three different explanations for this nse are suggest­
ed in the literature, first, increased Ca release from 
intracellular Ca stores, second, impaired reuptake 
into the stores (Blayney et al 1978, Hunter et al 
1982, Itoh et al 1981, Poledna and Morad 1983), 
and third, in vitro studies have shown that caffeine 
may cause increased transmembrane Ca influx 
(Blinks et al 1972, Kohlhardt et al 1974, Pang 1980) 
In order to investigate the role of the latter mech­
anism in the circulatory efTects of caffeine, haemody 
namic and humoral changes after cofTee have been 
investigated with and without previous blockade of 
the transmembrane Ca influx with the Ca slow chan­
nel blocker verapamil Besides theoretical interest, 
there is clinical relevance m question Is the pressor 
response to the dnnking of cofTee diminished during 
treatment with Ca slow-channel blocking agents9 
The caffeine was administered as a normal cofTee 
beverage since this is most relevant to daily life 
Subjects and Methods 
Ten healthy normotensive volunteers (6 men, 4 wom­
en) gave informed consent to the study All the sub­
jects were accustomed to dnnk cofTee each day, their 
mean intake ( ± SD) was 5 6 ± 2 0 cups of coffee per 
day (range 2-9) Age, height and body weight 
(mean±SD) of the group were 24 3 ± 6 1 years, 
179 3 ± 9 6 c m and 68 5 ± 9 1 k g , respectively Each 
subject took part in two cofTee tests, one after pla­
cebo and one after pretreatment with verapamil 
( 3 x 8 0 mg) The subjects were instructed to take 
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Fig. 1 BP, HR and FBF before and after coffee in the placebo 
and verapamil studies (niean±SEM) All haemodvnamic values 
after coffee are significantly changed, except those marked ns (not 
significant) 
2 tablets of the latter drug in the evening before the 
test, at 17 00 ρ m and 23 00 ρ m , and the third tablet 
45 mm before starting the coffee test All tests were 
performed in the morning between 8 15 a m and 
11 15a m The placebo and verapamil studies were 
separated from each other by at least one week, and 
the sequence of medication was evenly distributed 
over the subjects in a single-blind manner Before 
each test the subjects abstained from all methylxan-
thine-containing products for at least 24 h, and they 
were instructed not to smoke on the morning of the 
test. A light breakfast was allowed between 7 30 a. m 
and 8 00 a m 
The subject remained supine throughout the test. 
All parameters were measured before and for 2 h af­
ter coffee During the initial rest penod of 30 mm an 
antecubital vein in the right arm was cannulated for 
blood sampling. Artenosonde and Plethysmograph 
were connected to the left arm, which was placed in a 
support 5 to 10 cm above heart level After the penod 
of rest, blood pressure (BP) and heart rate (HR) were 
recorded 6 times at 5-min intervals In between four 
senes of three forearm blood flow measurements 
(FBF) were made, and blood was sampled for deter­
mination of basal blood levels of caffeine, plasma re­
nin activity (PRA) and catecholamines The subject 
was then asked to dnnk 2 cups of coffee within 
10 mm, whilst remaining supine Afterwards BP and 
HR were measured every 5 mm for 2 h Senes of 3 
FBF recordings were made between those measure­
ments Blood was sampled 60 and 120 mm after 
drinking the coffee For measurement of plasma caf­
feine concentrations an additional sample was taken 
after 40 mm, because some studies have shown peak 
plasma caffeine at different times (Ronati et al 1982, 
Robertson et al 1978) 
Coffee was prepared with a coffee machine, us­
ing 300 ml water and 20 g coffee, giving 2 cups of 
percolated coffee together containing about 240 mg 
caffeine BP was measured with an Artenosonde 
1225 and HR was calculated from the ECG FBF 
was measured using mercury-strain gauge venous 
occlusion plethysmography As only muscle flow 
was wanted, the skin flow in the hand was excluded 
by inflating a wnst cuff dunng all measurements 
Plasma caffeine was analyzed by a reversed-phase 
H PLC method (Smits et al 1983) Catecholamines 
were measured by a radioenzymatic assay (Hoffman 
et al 1982), and PRA by radioimmunoassay (Drayer 
and Benraad 1975) 
In each subject the mean values of all haemody­
namic parameters before and for each 20-min penod 
after coffee dnnkmg were compared The paired 
student's t test was employed for statistical analysis 
of the haemodynamic parameters in both studies 
Humoral parameters were analyzed by Wilcoxon's 
paired signed rank test in only 9 subjects, as blood 
sampling in one subject was incomplete Differences 
were considered to be statistically signficant at P-val-
ues of less than 5% (two-tailed) Mean artenal pres­
sure (MAP) was calculated as the sum of diastolic 
blood pressure (DBP) and one third of pulse pres­
sure Forearm vascular resistance (FVR) was calcu­
lated by dividing MAP into FBF and was expressed 
in arbitrary units The results are presented as 
mean ± SEM 
Results 
Mean values of all haemodynamic parameters in the 
20 mm penods both for the placebo and verapamil 
studies are shown in Fig 1. After placebo basal BP 
and HR were 112±4.0/68±24mm Hg and 75± 
2 2beats/mm, respectively. Pretreatment with ve­
rapamil did not significantly alter the basal values 
(108±3 3/69±19mmHg, 77beats/min), nor was 
there any difference in basal FBF in either study. 
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significantly increased in both the placebo and ve­
rapamil studies, by, respectively, 7 2 ± 3 0 and 9 1 + 
3 2 units There were no significant differences in the 
coffee-induced responses in any haemodynamic pa­
rameters between the placebo and verapamil studies 
Plasma caffeine levels were similar after pretreat­
ment with placebo and verapamil, the maximal val­
ues after 60 mm being 5 9 ± 0 5 and 6 1 ± 0 4 mg/1, re­
spectively After drinking coffee, plasma adrenaline 
rose significantly in both studies, whereas plasma 
noradrenaline did not change and PRA showed a 
significant fall (Fig 2) The percentage changes in 
PRA and plasma catecholamines after drinking cof­
fee in both studies are shown in Table 1 The cofTee-
induced responses in these humoral parameters were 
not significantly different in the two studies The bas­
al levels of caffeine and catecholamines, too, were 
unchanged after verapamil Basal PRA rose from 
1 11 ± 0 15 ng Ang I/ml h " ' after placebo to 1 84 ± 
0 30 ng Ang I/ml h " ' after verapamil (p < 0 05) 
No significant correlation was found between 
changes in haemodynamic and humoral parameters 
Discussion 
In the placebo study drinking coffee induced an im­
portant nse in BP, notably in DBP The increase was 
accompanied by a fall in HR and an ultimate nse in 
calculated FVR, whereas FBF did not change It is 
generally accepted that these findings should be con­
sidered as the result of the caffeine load, as caffeine 
is the only cardiovascular active drug in coffee (Eich-
ler 1976, Whittset et al 1984) The nse in plasma 
adrenaline after drinking coffee, as observed here, is 
in agreement with other observations (Izzo et al 
1983, Robertson et al 1978, Smits et al 1983) In vit­
ro studies have suggested that the nse may be the re­
sult of a direct stimulant effect of methyl xanthines 
on adrenal release of catecholamines (Poisner 1973) 
It may also be interpreted as a sign of increased stim­
ulation of the hypothalamo-sympatho-adrenal axis 
(Robertson et al 1978, Snider and Waldeck 1974) 
No correlation was found between the coffee-in­
duced changes in plasma adrenaline and systolic or 
Table 1 Percentage changes (%) in plasma levels of adrenaline (A), noradrenaline (NA) and plasma renin activity (PRA) 60 and 120 mm 
after coffee in the placebo and verapamil studies (mean ± SEM) 
Time 
(mm) 
A(%) 
NA(%) 
PRA (%) 
Placebo 
60 
132 ±22 8 
6 9 ± 95 
- 1 8 1 ± 1 0 5 
120 
257 ±58 1 
9 2 ± 86 
- 2 7 3 ± 65 
Verapamil 
60 
128 ±25 3 
2 5 ± 74 
- 1 9 4 ± 6 0 
120 
266 ±75 0 
I 4 8 ± 8 9 
- 3 3 0 ± 68 
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There was a continuous nse in BP following inges 
tion of the coffee In the placebo and verapamil 
studies the increase in systolic and diastolic blood 
pressures (SBP/DBP) 2 h after coffee were, respec­
tively, 7 ± 1 7/14±16mmHg and 7 ± 1 9 / 1 2 ± 
1 0 mm Hg The pulse rate decreased after drinking 
coffee, with a maximal fall of 7beats/min in the 
placebo study and 9 beats/mm after pretreatment 
with verapamil The coffee-induced changes in SBP, 
DBP, MAP and HR were statistically significant in 
both studies In the verapamil study FBF showed a 
significant nse in the first 20-mm penod (/><0 05) 
The ultimate fall in FBF of 0 2 ml/100 ml mm in 
both studies after coffee was not significant Two 
hours after coffee, however, the calculated FVR was 
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Fig 2 Plasma levels of adrenaline (E) noradrenaline (NE), caf 
feme (cf) and PRA before (0) and 40 60 and 120 min after cofTee 
(mean ± SEM) DilTerences from baseline in the placebo and ve 
raparmi studies were statistically tested */><0 05 **p<0§\ 
•**/><0001 ns not significant 
diastolic blood pressure, so the role of the increased 
level of plasma adrenaline in the haemodynamic ef­
fects induced by coffee still remain unclear It was 
not possible to confirm the increase in PRA after caf­
feine ingestion reported by others (Robertson et al 
1978), but the present results are in close agreement 
with our previous observations on the elTect of drink­
ing coffee (Smits et al 1983) Perhaps an increase in 
PRA after coffee may occur only after a longer peri­
od of abstinence from caffeine, as tolerance to the 
humoral effects of caffeine has been described (Ro­
bertson et al 1981) 
One possible explanation for the fall of PRA in 
both studies is the arcadian rhythm of PRA since all 
tests were performed in the morning (Modlinger et 
al 1976) 
Pretreatment with verapamil did not significantly 
change basal haemodynamics in the study Muiesan 
et al (1981) also concluded that verapamil adminis­
tered acutely did not alter BP or pulse rate in normo-
tensive subjects The basal values of plasma cate­
cholamines did not reveal significant differences 
after placebo or verapamil The only humoral pa­
rameter changed after verapamil was the rise in 
PRA, probably caused by stimulation of the renin-
angiotensin system as a result of peripheral vasodila 
tion (Koch-Weser 1974) The slightly higher basal 
values of HR and plasma catecholamines in the ve­
rapamil study might be a consequence of the vasodi­
lator effect of verapamil The results may indicate 
that after short-term verapamil administration the 
balance between the well-known negative chrono­
tropic effect of verapamil and the reflex tachycardia 
resulting from its vasodilator effect is turned in fa­
vour of the latter (Saini 1984) 
Verapamil was used here as a slow Ca-channel 
blocking drug, in the dose of 240 mg over 14 5 h A 
single dose of 160 mg verapamil orally or 
7 5 12,5 mg iv causes vasodilatation in man 
(Muiesan et al 1981, Vincenzi et al 1976), and as evi­
dence of vasodilation after verapamil was seen in our 
subjects, it can be assumed that the transmembrane 
Ca influx was sufficiently blocked in this expen-
ment 
Several pharmacological activities of caffeine 
might be responsible for its circulatory effects The 
increase in circulating catecholamines after caffeine 
may induce a rise in intracellular cyclic adenosine 
monophosphate, and so caffeine might exert a posi­
tive inotropic effect This could be enhanced by the 
caffeine-mediated inhibition of the enzyme phos­
phodiesterase (Beavo et al 1970) Antagonism of en­
dogenous adenosine (Fredholm 1980) and central 
mechanisms may also contribute to the cardiovascu­
lar effects of caffeine (Thelen 1965, personal com­
munication) As mentioned in the introduction, there 
is also evidence of an increased intracellular Ca con 
centralion after caffeine in mammalian heart and 
smooth muscle cells (Blinks et al 1972, Itoh et al 
1981) In the present study there were similar hae­
modynamic and humoral responses to dnnkmg cof­
fee in the placebo and verapamil studies According 
to the similar time course and height of the plasma 
caffeine levels in the two studies, the body load and 
kinetics of caffeine were the same after placebo and 
verapamil The similarity of the circulatory response 
to the load in both studies indicates that pretreat 
ment with the slow Ca-channel blocker verapamil 
had not inhibited the cardiovascular effects of drink­
ing coffee In studies in vitro an increased cytoplas­
mic Ca has been observed after caffeine, which ap­
peared to be the result of caffeine-induced release of 
Ca from intracellular stores (Hunter et al 1982, Itoh 
et al 1981) and impaired Ca re-uptake in those stores 
(Blayney et al 1978, Poledna and Morad, 1983, 
Shine and Langer 1971) Since verapamil exerts no 
effects on intracellular Ca mobilization, the present 
study was unable to contribute to evaluation of the 
role of these mechanisms in the circulatory effects of 
caffeine 
It is concluded that the role of calcium in the car­
diovascular effects of drinking coffee, if any, may be 
of intracellular origin and seem not to involve 
changes in transmembrane calcium influx The con­
tributions of the other pharmacological mechanisms 
mentioned to the circulatory effects of coffee inges­
tion have still to be explored 
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SUMMARY 
To assess the contribution of circulating epinephrine to the 
cardiovascular effects of drinking coffee, we studied the hemo-
dynamic and humoral response to coffee in 10 normotensive, 10 
bilaterally adrenalectomised and 10 hypertensive suojects. In the 
normotensive group drinking coffee exerted a rise in blood 
pressure (+5.1/+11.5 mmHg), a fall in heart rate (-6.0 bpm), a 
rise in plasma epinephrine (-«-257.2%), and no change in plasma 
norepinephrine. The response to coffee in the hypertensive group 
was similar or even enhanced. In the adrenalectomised patients 
the coffee-induced rise in diastolic blood pressure was attenua-
ted (+7.9 mmHg; P<0.U5), whereas plasma norepinephrine showed a 
fall (-20.8%) and plasma epinephrine remained undetectable 
throughout all tests. Additionally, a fall in plasma renin 
activity after coffee was observed in all 3 groups. We conclude 
that the pressor response to coffee is not purely due to circu-
lating epinephrine, or to stimulation of the renin-angiotensin-
aldosterone system. On the other hand, the coffee-induced 
increase of plasma epinephrine may increase the pressor response 
to coffee. 
41 
INTRODUCTION 
In previous studies we ascertained that drinking 2 cups of 
coffee induced considerable changes in blood pressure, heart rate 
and plasma epinephrine, and that these effects were due to the 
caffeine load(1,2,3). With respect to the pharmacological basis 
of these effects there is still much incertitude. In several 
organ systems the variety of physiologic and biochemical effects 
of caffeine resemble the effects of sympathomimetic drugs, and 
therefore it was suggested that the increase of plasma epine-
phrine after methylxanthines should be responsible for its circu-
latory effects(4). As caffeine and coffee have been reported res-
pectively to raise(5) and to lower plasma renin activity(l), the 
importance of the renin-angiotensin-aldoaterone system with res-
pect to the effect of coffee on blood pressure also remains un-
clear. 
Our first aim of this study was to find out what is the role 
of increased levels of plasma epinephrine in the circulatory ef-
fects of coffee and therefore we analysed the hemodynamic and hu-
moral response to coffee in patients, who were adrenalectomised 
bilaterally. Additionally, we were interested in the plasma renin 
activity before and after coffee in this group. To answer these 
questions we performed coffee tests in adrenalectomised patients 
as well as in normotensive healthy subjects. Since mean blood 
pressure is higher in adrenalectomised patients similar coffee 
tests were performed in hypertensive subjects also. 
PATIENTS AND METHODS 
Ten normotensive subjects, 10 patients with Cushing's disease 
who had been treated previously by bilateral adrenalectomy and 10 
hypertensive patients gave their informed consent for this study, 
which was approved by the ethical committee of the hospital. All 
healthy volunteers were used to daily coffee ingestion, with a 
mean intake of 5.6±0.6 cups of coffee per day. In the hyperten-
sive and adrenalectomised group, all patients but one of each 
group were habitual coffee users, but the mean intake of coffee 
42 
in the 3 groups did not differ significantly. The time between 
bilateral adrenalectomy and the coffee tests averaged 53.0 ± 26.3 
months (range 0.5 - 252) and all adrenalectomised patients were 
substituted with cortisone (9x), or prednisone (1x) and 9-o-fluo-
rocortisol (10x). From all hypertensive patients 2 had reno­
vascular hypertension, whereas the others were suffering from 
essential hypertension, and none of them had medication. Table I 
gives some other relevant characteristics of the 3 groups. 
After a period of caffeine abstinence of at least 24 hr all 
subjects participated in a coffee test. All tests were performed 
in the morning from Θ.15 - 11.15 hour. A light caffeine-free 
breakfast was allowed between 7.30 and Θ.00 am. Smoking was not 
allowed in the morning of the test. Throughout the whole test the 
subjects remained in the supine position. In an initial equili­
bration period of 30 minutes an antecubital vein of the right arm 
was cannulated for blood sampling. The left arm was placed in an 
arm support 5 to 10 cm above heart level, and this arm was used 
for blood pressure monitoring by an Artenosonde 1225, and for 
measuring forearm blood flow by strain-gauge venous occlusion 
plethysmography. Heart rate was measured by ECG. After equilibra­
tion systolic and diastolic blood pressure (SBP, DBP) and heart 
rate (HR) were measured every 5 minutes for 6 times. Meanwhile 4 
series of 3 forearm blood flow registrations (FBF) were made and 
blood was sampled for the determination of basal concentrations 
of caffeine, plasma renin activity (PRA), catecholamines, and in 
the hypertensive group also plasma aldosterone. After the basal 
measurements the subjects were asked to drink 2 cups of regular 
coffee within 10 minutes in the supine position with the aid of a 
straw. Subsequently, SBP, DBP and HR were registered each 5 
minutes for 2 hours, and meanwhile again series of 3 FBF regis­
trations were made. Blood was sampled again at 60 and 120 minutes 
after the ingestion of coffee. 
Coffee was prepared with a coffee machine using 300 ml of 
water and 20 grams coffee, and this resulted in 2 cups of coffee 
containing together about 240 mg caffeine. Plasma caffeine con­
centrations were analysed with a reversed-phase HPLC-method(1), 
plasma catecholamines by radioenzymatic assay(6) and PRA by 
radioimmunoassay(7). In this study no tests with placebo or 
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Table I: Some relevant characteristics of the 3 groups of 10 subjects (Mean ± SE, range between brackets). 
N0RM0TENSIVES ADRENALECTOMISED HYPERTENSIVES 
Sex (M/F) 
Age (years) 
Length (cm) 
Weight (kg) 
Quetelet-index (kg/m ) 
6/4 
2A.3 ± 1.9(19-37)» 
179 ± 3(168-201)* 
68.5 ± 2.9(54.4-85.0) 
21.3 ± 0.5(19.3-24.3) 
1/9 
36.9 ± 4.0(19-56) 
167 ± 4(144-184) 
60.3 ± 4.4(42.0-75.1) 
21.4 ± 0.8(17.8-25.4) 
3/7 
39.0 ± 4.3(18-56) 
168 ± 2(158-179) 
66.3 ± 3.3(53.0-84.0) 
23.4 ± 0.8(19.0-27.7)** 
Endogenous Creatinine 
Clearance (ml/min) 
Plasma-sodium (mmol/l) 
Plasma-potasaiLin (mmol/l) 
Plasma Cortisol (pmol/l) 
142.3 ± 0.6(140-145) 
3.6 ± 0.1(3.1-4.0) 
0.26 ± 0.06(<0.02-0.50) 
104 ± 7(82-155) 
140.6 ± 0.7(138-142) 
4.1 ± 0.1(3.7-4.6) 
* P<0.05 vs adrenalectomised/hypertensive 
** P<0.05 vs normotensive 
decaffeinated coffee were performed, firstly because we previous-
ly studied the circulatory effects of coffee in a placebo-
controlled manner(3), and secondly because the aim of this study 
was only to compare the response to coffee in 3 different groups. 
To evaluate the hemodynamic coffee-induced changes for each 
group, variables were averaged for each 20 minute period after 
coffee and compared to mean basal values with Student's t-test 
for paired observations. For comparing the changes after coffee 
in the 3 different groups, the mean change over the complete 
2-hour period after coffee was calculated, and these values were 
compared with each other by Student's t-test for unpaired obser-
vations. Humoral parameters were analysed in the same way with 
Wilcoxon's 2 sample test and with Wilcoxon's paired rank test. 
Differences were considered to be statistically significant at 
P-values of less than 0.05 (2-3ided). Correlation coefficients 
were calculated according to Pearson. Mean arterial pressure 
(MAP) was calculated as the sum of DBP and one third of pulse 
pressure. Forearm vascular resistance (FVR) was calculated by 
dividing MAP through FBF and was expressed in arbitrary units 
(U). All results are presented as mean ± SE, unless indicated 
otherwise. 
RESULTS 
Table I shows that mean age in the normotensive group was 
lower, and mean length higher than in both other groups. In the 
hypertensive patients Quetelet-index was higher when compared 
to the normotensive group. Table II summarizes the basal values 
of all hemodynamic and humoral parameters. As expected mean basal 
blood pressure of the hypertensive patients was significantly 
higher than of both other groups. Between the normotensive and 
adrenalectomised subjects there were no significant differences 
in mean SBP and MAP. Basal DBP, however, was higher in the adre-
nalectomised patients. Mean basal values of HR and FVR revealed 
no significant differences between the 3 groups, whereas basal 
FBF appeared to be higher in the hypertensive patients. 
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*> Table II: Mean basal values (±5E) of all hemodynamic and humoral parameters of the 3 groups of 10 subjects 
NORMOTENSIVE P1 ADRENALECTOMISED P2 HYPERTENSIVE P3 
HEMODYNAMIC 
Systolic blood pressure (mmHg) 
Diastolic blood pressure (mmHg) 
Mean arterial pressure (mmHg) 
Heart rate (bpm) 
Forearm blood flow (ml/100 ml.min) 
Forearm vascular resistance (U) 
HUMORAL 
Caffeine (mg/l) 
Epinephrine (nmol/1) 
Norepinephrine (nmol/1) 
Plasma renin activity (ng/ml.hr"^) 1.11+0.15 
111.614.0 
68.3+2.4 
82.8+2.7 
74.7+2.2 
2.6+0.3 
34.8±3.4 
ns 
P<0.05 
na 
ns 
ns 
ns 
116.5+5.7 
78.4+3.8 
91.1±4.0 
76.6±2.4 
2.5+0.2 
39.7±3.7 
P<0.01 
P<0.01 
P<0.01 
ns 
P<0.05 
ns 
150.3+6.9 
99.6±4.7 
116.5+5.3 
75.9+3.3 
3.6±0.4 
37.3±5.1 
P<0.001 
P<0.001 
P<0.001 
ns 
P=0.07 
ns 
0.2 ±0.04 
0.0910.02 
0.9910.08 
ns 
P<0.01 
ns 
ns 
0.1+0.1 
ND(<0.05) 
2.0310.30 
1.44+0.49 
ns 
P=0.0002 
P<0.05 
ns 
ND « 0.1) 
0.1310.03 
1.19+0.12 
1.95+0.70 
ns 
ns 
ns 
ns 
P1= normotensive vs adrenalectomised; P2= adrenalectomised vs hypertensive; P3= normotensive vs hypertensive 
п = not significant; ND= not detectable 
Figure 1 presenta the mean values of SBP, DBP, HR and FBF be-
fore and for all 20-minute periods after coffee of the 3 groups. 
In the normotensive subjects coffee induced a rise in SBP from 
111.6+4.0 to 118.3+4.0 mmHg (P<0.01), and in DBP from 68.3±2.4 to 
82.6+2.1 mmHg (P<0.0001) in the last 20-minute period. This 
corresponds with a percentual rise in DBP of 21.5+2.8%. MAP rose 
from 82.8±2.7 to 94.5±2.4 mmHg after coffee (P<0.001). Mean HR 
showed a fall from 74.7±2.2 to 67.4+2.3 bpm (P<0.001). Drinking 
coffee did not result in FBF-changes in the normotensive sub-
jects. After an initial insignificant fall, mean FVR showed a 
small rise of 7.2+3.0 U in the last 20-minute period (P<0.05). 
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Figure 1 ; Mean (±SE) values of blood pressure, heart rate and 
forearm blood flow before and for each 20-minute period 
after coffee in the normotensive, adrenalectomieed and 
hypertensive subjects. All values after coffee were 
significantly different from baseline values, unless 
signed with NS (not significant). 
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In the adrenalectomised patients SBP and DBP also were increa-
sed after coffee with respectively 6.5+1.4 and 9.2±1.6 mmHg 
(P<0.01 and P<0.001). Mean HR decreased after coffee with a 
maximum in the 3rcl 20-minute period (-7.9+1.8 bpm; P<0.01). 
Mean FBF remained almost unchanged, with only a slight fall of 
-0.3 + 0.2 ml/100 ml .mm (P = 0.07). From 20 minutes after coffee to 
the end of the test mean FVR was increased when compared to basal 
values (P<0.05). 
The hypertensive subjects also showed an increase in blood 
pressure after coffee. MAP rose from 116.5±5.3 to a maximum of 
131.0+5.7 mmHg in the 3r^ 20-minute period after coffee 
(P<0.001). HR fell from 20 minutes after coffee to the end of the 
test with a maximum of -5.7+1.4 bpm (P<0.01). Drinking coffee 
initially raised FBF from 3.6 + 0.4 to 4.6 + 0.7 ml/100 ml.mm 
(0.05<P<0.1) but afterwards FBF ranged from 3.9±0.8 to 4.2+0.6 
ml/100 ml.mm. being not significantly different from baseline 
values. FVR firstly showed a fall from 37.3±5.1 to 32.9±5.2 U 
(P=0.09) and ultimately a small but not significant rise to 
40.0±4.5 U. 
Figure 2 shows the mean hemodynamic changes over the entire 
2-hour period after coffee in the 3 groups. In the hypertensive 
patients the rise in SBP and MAP was larger than in both other 
groups. As a result of the higher basal values of blood pressure 
in the hypertensive group, the fractional changes in SBP and MAP 
showed no significant differences in the 3 groups. Mean rise of 
DBP of 7.9+1.1 mmHg in the adrenalectomised group was signifi-
cantly smaller than in the normotensive (11.5+1.0 mmHg; P<0.05) 
and in the hypertensive subjects (11.3+1.2 mmHg; P<0.05). There 
were no differences in the coffee-induced changes of HR and FBF 
between the 3 groups. However, the rise in calculated FVR in the 
adrenalectomised patients of 11.4+3.4 U was greater than the rise 
in both other groups (Fig. 2). 
Mean basal values of plasma caffeine, catecholamines and PRA 
are summarized in Table II. Individual basal plasma caffeine 
ranged from <0.1 to 0.6 mg/1. There were no significant diffe-
rences in mean basal plasma caffeine between the 3 groups. As 
expected, plasma epinephrine was below the level of detection in 
all adrenalectomised patienta (<0.05 nmol/1). Basal plasma 
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catecholamines revealed no differences between normotensive and 
hypertensive subjects. In the adrenalectomised patients plasma 
norepinephrine was significantly higher than in the hypertensive 
group. We did not observe differences in baseline PRA between the 
3 groups. 
Figure 3 shows mean values of plasma caffeine, catecholamines 
and PRA before and after coffee. In the normotensive and adrena­
lectomised subjects mean plasma caffeine was maximal 60 min after 
coffee, and in the hypertensive group 120 minutes after coffee. 
Peak plasma levels were similar and measured 5.9+0.5, 5.B+0.5 and 
6.2+0.3 mg/1 respectively. In normotensive, adrenalectomised and 
hypertensive subjects mean PRA showed a fall of respectively 
-27.3±6.5, -14.1+4.7 and -B.7±6.0S, which only reached signifi­
cance in the normotensive and adrenalectomised subjects. The 
changes of PRA were statistically not different between the 3 
groups. In the hypertensive subjects mean basal plasma aldoste­
rone numbered 6.3 ± 1.9 ng/100 ml, and remained unchanged after 
coffee. Plasma epinephrine did not reach detectable levels after 
coffee in the adrenalectomised patients, whereas in both other 
groups a significant rise was observed. The mean maximal rise of 
plasma epinephrine of 257.2±58.1% in the normotensive group was 
not significantly different from the rise of 115.1+21.4й in the 
hypertensives. In the normotensive and hypertensive subjects 
plasma norepinephrine hardly changed after coffee whereas a sig­
nificant decrease was observed in the adrenalectomised group. 
This latter fall of -20. +7.7Ж waa significantly different from 
the rise of 2.918.6* in the hypertensive group (P<0.05). 
There were no significant correlations between changes of humoral 
parameters and hemodynamic changes. 
DISCUSSION 
Several years after the observation that the urinary excretion 
of catecholamines was increased by methylxanthines in man(8,9), 
valid laboratory methods became available to ascertain increased 
plaema catecholamines (especially epinephrine) after caffeine and 
coffee(1,5). This rise in plasma epinephrine could be the result 
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Figure 3; Mean (+SE) plasma concentrations of caffeine, PRA and 
catecholamines before (0) and 60 and 120 minutes after 
coffee in normotenaive, adrenalectomised and hyper­
tensive subjects 
*P<0.05; *»P<0.01} ***P<0.001; NS= not significant 
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of a direct effect of methylxanthines on the adrenal gland(10,11) 
or of the increased stimulation of sympathetic nerves to the 
adrenal medullaC12) . Recent reports show that drinking coffee 
induces a rise in blood pressure(1,2,3) but until now the role of 
increased plasma epinephrine in the circulatory effects of 
caffeine is not clear. 
In this study we analysed the hemodynamic and humoral effects 
of drinking coffee in 10 adrenalectomised patients, in 10 normo-
tensive subjects and in 10 hypertensive subjects. The observa-
tions in normotensive subjects closely agree with former reports 
(1,2,3). In the adrenalectomised patients coffee elevated blood 
pressure, but the rise in DBP was attenuated when compared to 
both other groups, whereas the increase of plasma caffeine was 
the same. The higher age of the adrenalectomised groups could not 
account for this difference because the circulatory response to 
coffee increases with age(13). It may be assumed that there were 
no differences in the water- and sodium balance between the 3 
groups, firstly because there were no differences in basal PRA 
and secondly because in the adrenalectomised patients plasma 
sodium, potassium and Cortisol all were within the normal range 
(Table I ) . 
It is interesting to hypothesize that the smaller DBP-nse in 
the adrenalectomised group is the result of the lack of circula-
ting epinephrine. With respect to this, another striking observa-
tion was the fall of plasma norepinephrine in the adrenalecto-
mised patients, whereas in the other groups no change was obser-
ved, and in comparable atudies even a small rise of plasma nor-
epinephrine haa been reported(1,2,5). Indeed, a decline in plasma 
norepinephrine would be the expected passive response of the sym-
pathoadrenal system to an extrinsic pressor stimulus. Consequent-
ly, our data may suggest that drinking coffee results in a pres-
sor response without mediation of the sympathoadrenal system 
(adrenalectomised group), but that this pressor response may be 
enhanced by caffeine-induced circulating epinephrine (normoten-
sive and hypertensive group). The physiologic substrate for this 
observation could be the stimulation of presynaptic ß2-receptor3 
by epinephrine(14). The phenomenon of increased sympathetic tone 
as a result of circulating epinephrine in rats has already been 
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suggested by Majewski et al(15). The observation that bilateral 
adrenal demedullation of hypertensive rats attenuated the pressor 
response to sympathetic nerve stimulation also partly supports 
this hypothesis(16) . 
A recent article of Onrot et al(17) reported about the circu-
latory effects of caffeine in autonomic failure. In that study no 
statistical comparison with healthy subjects was performed, but 
the results indicate that the pressor effect to caffeine is not 
primarily due to elevations in sympathoadrenal activity. However, 
in autonomic failure both adrenergic and noradrenergic mechanisms 
are partially blunted and so the possible role of circulating 
epinephrine on an intact autonomic nervous system can not be stu-
died . 
In the adrenalectomised patients coffee induced a rise in FVR 
whereas this was not observed in the other groups (Figure 2). 
This may be the expression of an altered balance between the P2-
mediated vasodilation in the forearm muscle by epinephrine after 
coffee, the direct action of caffeine on smooth muscle cells(1B) 
and an altered sympathetic tone of the forearm vessels. 
In former reports(1,2,3) and in this study drinking coffee 
induced a fall in PRA, whereas Robertson et al observed an in-
crease in PRA after 250 mg caffeine(5). We have no clear explana-
tion for those contradictory results, but our and other recent 
findings(17) suggest that the rise in blood pressure after coffee 
is not mediated by the renin-angiotensin-aldosterone system. 
As suggested in a former study(19) our results indicate that 
the pressor response to coffee seemed elevated in hypertensive 
patients when compared to normotensive subjects. The significant 
higher age of the hypertensive patients may contribute to this 
phenomenon(13) . Apart from that, it must be realised that frac-
tional rises in blood pressure after coffee were broadly the same 
in normo- and hypertensive subjects. However, our observations 
and those from recent literature(20,21) show that the pressor 
response to coffee in hypertensive patients resembles or even 
surpasses the effects in normotensive subjects and this may 
emphasize that the circulatory effects of coffee may have 
epidemiological, clinical and therapeutic consequences for the 
problem of high blood pressure. 
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In conclusion, drinking coffee exerts a rise in blood pres­
sure, a fall in heart rate, and a rise in plasma epinephrine in 
normotensive as well as in hypertensive subjects. In the adrena-
lectomised group coffee also induced a pressor response, but the 
rise in DBΡ was attenuated and plasma norepinephrine fell signi­
ficantly, whereas plasma epinephrine remained undetectable 
throughout the tests. We suggest that the rise in blood pressure 
after coffee is not the result of an increase in circulating epi­
nephrine. However, the latter may exaggerate the pressor response 
to coffee, by an epinephrine-mediated increase in sympathetic 
tone. Further, our data indicate that the rise in blood pressure 
after coffee is not mediated by the renin-angiotensin-aldosterone 
system. Until now, the pharmacological mechanism of the circula­
tory effects of caffeine in man remains unclear, and we think 
this item deserves further studies in man. 
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EVIDENCE FOR AN ANTAGONISM BETWEEN CAFFEINE AND ADENOSINE IN THE 
HUMAN CARDIOVASCULAR SYSTEM. 
P. Smits, P. Boekema, R de Abreu*, Th. Thien and A. van 't Laar 
Submitted for publication 
Division of General Internal Medicine, Department of Medicine 
atnc Oncology, Departn 
University of Nijmegen 
and *Centre for Pedi tri ment of Pediatrics 
57 

SUMMARY 
A randomized, double-blind and placebo-controlled study was 
performed in 10 normotensive male subjects to analyse a possible 
antagonism between caffeine and adenosine with respect to their 
effects on the cardiovascular system in man. Caffeine, 250 mg 
intravenously, increased blood pressure with V/12 mm Hg, and 
resulted in a fall in heart rate of 3 bpm. Plasma epinephrine 
rose with 114л after caffeine. Adenosine, in an increasing dose 
of 0.04-0.16 mg/kg/min induced an increase in systolic blood 
pressure (17 mm Hg; and heart rate (33 bpm), a moderate fall in 
diastolic blood pressure (-4 mm Hg), and no change in mean 
arterial pressure. Forearm blood flow, skin' temperature and 
transcutaneous oxygen tension were lowered at the highest adeno­
sine infusion rates. Adenosine induced a strong rise of plasma 
( nor;epinephrine (resp. 227.2л and 215.9л). The fractional 
changes in systolic blood pressure, heart rate, plasma catechol­
amines, plasma renin activity and aldosterone, supposed to be 
induced by adenosine-mediated regional vasodilation, all were 
significantly reduced after previous administration of caffeine. 
Our results indicate an interaction between caffeine and 
adenosine in man, supporting the hypothesis that caffeine exerts 
its circulatory effects by competitive antagonism of endogenous 
adenosine. 
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INTRODUCTION 
Caffeine and other methylated xanthines have been reported to 
affect many different organ systems (1). Previously, we have 
shown relevant effects of drinking coffee on the cardiovascular 
system (2,3;. According to these results and the literature, the 
most striking caffeine-induced circulatory changes are the rise 
in blood pressure, due to an increased vascular resistance, and a 
fall in heart rate (2-5). In addition, caffeine elevates plasma 
epinephrine, and to a lesser extent, plasma norepinephrine (2,3, 
5 ) . The pharmacological basis of these effects still has not been 
fully elucidated. From some reports, however, there is evidence 
that the caffeine-induced effects may be due to antagonism of en-
dogenous adenosine (6). In both in-vitro and in-vivo studies the 
antagonism between adenosine and caffeine has been observed at 
caffeine concentrations which are likely to occur in daily life 
(6), whereas much higher concentrations are needed to demonstrate 
other possible pharmacological modes of action of caffeine, such 
as inhibition of the enzym phosphodiesterase (7), or changes of 
intracellular calcium concentration (1). In laboratory animals 
adenosine behaves as a potent vasodilating agent in cerebral, 
intestinal and coronary circulation (8,9,10), whereas renal vas-
cular resistance increases during adenosine infusion (11). In 
man, the circulatory effects of adenosine have hardly been 
studied, whereas these effects and the interaction with caffeine 
could provide interesting results with respect to the concept of 
human punnergic cardiovascular receptors. Firstly, a caffeine-
induced inhibition of vasodilating effects of endogenous adeno-
sine would explain the well-documented pressor response to the 
drinking of coffee. Additionally, adenosine increases coronary 
blood flow and may be involved in several physiological and 
pathophysiological processes of the cardiovascular system 
(12,13,14,15). Consequently, the hemodynamic effects of adenosine 
and its putative inhibition by caffeine, a drug daily ingested by 
a lot of people, could be of theoretical and clinical importance. 
Therefore, we performed a randomized, double-blind and placebo-
controlled study to find out whether some circulatory effects of 
exogenous adenosine are changed by prior caffeine administration. 
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SUBJECTS AND METHODS 
After approvement of the local hospital ethical committee 10 
healthy normotensive male volunteers were selected and gave their 
written informed consent for this study. The mean (± SD) (and 
range) of age, height, weight and Quetelet-index of the subjects 
numbered respectively 26.3±6.2 years (20-42), 184.7+6.4 cm (177-
197), 73.7±8.6 kg (62-86) and 21.6+2.6 kg/m2 (18.4-25.5). The 
subjects were used to daily caffeine intake and mean (+ SD) 
coffee use was 3.3±2.2 cups of coffee per day (range 1-6.5 cups/ 
day) . 
To be sure that intravenous administration of caffeine exerts 
similar effects as the oral ingestion of coffee in previous stu-
dies (2,3), we firstly performed a "caffeine-test", with regis-
tration of hemodynamic and humoral parameters before and after 
caffeine i.V.. Subsequently, the subjects took part in 2 
"adenosine-tests" in a randomized order. In those tests adenosine 
was infused after previous double-blind administration of 
caffeine or placebo. The schedule of measurements of the 
caffeine-test and the 2 adenosine-tests was the same, and all 
tests were performed in the morning from 9.00 to 11.20 hour. The 
subjects were asked to refrain from smoking the morning before 
the test, and from caffeine-containing products for at least 24 
hours before the start of each test. A light caffeine-free 
breakfast was allowed one hour before entering the laboratory. 
Each test started with an equilibration period of 30 minutes 
and the subjects remained in the supine position from the begin-
ning to the end of the test. During equilibration an Arterioaonde 
1225 (semi-automatic blood pressure monitoring) and a 
strain-gauge venous occlusion Plethysmograph were connected to 
the subjects left arm for monitoring blood pressure and forearm 
blood flow. Chest electrodes were connected to calculate heart 
rate by ECG. On the right hand, skin temperature was measured 
with a thermocouple(index finger), and transcutaneous oxygen 
tension was measured by a Tacomette(middle finger). In the 
meantime an antecubital vein of the left and right arm was 
cannulated for sampling and drug infusion, respectively. 
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After equilibration basal hemodynamic values were registered 
during 10 minutes: 5x systolic and diastolic blood pressure (SBP, 
DBP), 5x heart rate (HR), 4x forearm blood flow (FBF) and 3x skin 
temperature and transcutaneous oxygen tension (ST, T
c
p02). At 
the same time blood was sampled for determination of plasma con­
centrations of caffeine, catecholamines, renin activity (PRA), 
aldosterone, potassium and adenosine with its degradation pro­
ducts inosine and hypoxanthine. Next, caffeine (250 mg caffeine-
sodium benzoate in 20 ml glucose 5%) was infused during the 
caffeine-test in 10 minutes, and in the adenosine-tests placebo 
or caffeine was infused. Subsequently, a 10 minute-period of 
hemodynamic registrations was performed and blood was sampled for 
all humoral variables. From 60 to 120 minutes after the start of 
the adenosine-tests, adenosine was continuously infused with 
rates of 0.04, 0.0B, 0.12 and 0.16 mg/kg/min, each lasting 15 
minutes. The last 10 minutes of every dose, again a series of 
hemodynamic parameters were registered. The adenosine solution 
(10 mg/ml in sodium chloride 0.9%) was proved to be stable, with 
unchanged concentrations after 2 weeks of storage. The З1-1^ 
sample for all humoral variables was taken at the end of the 
highest adenosine infusion rate, 120 minutes after the start of 
the test. After finishing the infusion, recovery of all hemody­
namic variables was monitored for another 15 minutes. In the 
caffeine-test the same registrations were made, but no adenosine 
was infused. Figure 1 illustrates the protocol of the tests. 
Plasma caffeine concentration was determined with a HPLC-
method (2). For determination of plasma adenosine, inosine and 
hypoxanthine a special sampling procedure was used to prevent 
rapid loss of adenosine from plasma. Two ml of venous blood was 
mixed with 2 ml of a prepared cooled saline solution. This solu­
tion contained 20 μΜ dipyndamol to inhibit adenosine uptake into 
blood cells (16), 10 μΜ deoxycoformicine to block adenosine 
deaminase in plasma (17) and 2 \ig/ml of indomethacin to prevent 
nucleotide release from thrombocytes during centnfugation (18). 
This mixture was immediately centnfuged at 3000 rpm for 10 
minutes, and then the supernatant was frozen at -20°С The 
contentration of adenosine, inosine and hypoxanthine in the 
mixture were determined with a HPLC-method (19). Because the 
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^ Figure 1 ; Schedule of measurements of the caffeine-test (test A) and the 2 adenosine-tests (test B&C) 
the blood samples were diluted, we adjusted for the packed cell 
volume. Plasma catecholamines were measured by a radioenzymatic 
assay (20), and PRA (21) and aldosterone (22) by radioimmuno­
assay. Potassium concentration was determined with an automatic 
flame fotometer (corning type 460). 
Statistical analysis 
All hemodynamic parameters were averaged for every period of 
10 minutes to one mean value. Mean arterial pressure (MAP) was 
calculated from these values as the sum of DBP and 1/3Γ(1 of 
pulse pressure, forearm vascular resistance (FVR) was calculated 
by dividing MAP through FBF and presented in arbitrary units 
(U).In the 2 tests where caffeine or adenosine was administered 
as the only drug, the circulatory effects of that drug were de­
monstrated by comparing post-intervention values to basal values. 
To study the interaction between caffeine and adenosine, we 
compared the means of all adenosine-induced fractional changes 
after placebo and after caffeine with each other, using the 
post-caffeine (or -placebo) values as basal values. All hemodyna­
mic parameters were analyzed by paired Student-t-test, and humo­
ral parameters by paired Wilcoxon-test. Differences were consi­
dered to be statistically significant at P-values of less than 
0.05 (2-sided). Correlation coefficients were calculated accor­
ding to Pearson. All results are presented as mean + standard 
error of the mean (SEM), unless indicated otherwise. 
RESULTS 
The ultimate calculations were performed in 9 subjects, 
because basal plasma caffeine concentration of 1 subject was too 
high (reap. 3.0 and 4.2 mg/1), indicating that the instructions 
with respect to caffeine abstinence were not followed. 
The circulatory effects of caffeine alone 
Figure 2 shows the hemodynamic results of single caffeine-
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infusion. SBP rose from 112.0±4.5 to ultimately 121.2±4.0 mm Hg 
(P<0.05), DBP from 67.1+3.1 to 79.4±3.0 mm Hg (P<0.001), and MAP 
from 82.0±3.2 to 93.4+3.2 mm Hg (P<0.001). HR slightly decreased 
from 63.4±2.5 to 60.1+2.7 bpm (P<0.05). FBF and calculated FVR 
hardly changed after caffeine. Plasma caffeine rose from 0.9 ± 
0.1 to 7.0 ± 0.3 mg/l immediately after infusion of caffeine, and 
decreased to 5.2+0.2 mg/l at the end. Plasma epinephrine 
increased significantly with 114.2±19.755 (P<0.01), whereas 
norepinephrine remained unchanged. PRA showed a fall of 44.9+7.35Í 
(P<0.01), and no changes in plasma potassium, aldosterone, 
adenosine or its degradation products were found after caffeine 
infusion. 
The circulatory effects of adenosine alone 
Figure 3 shows the response of blood pressure and HR to adeno-
sine after placebo and after caffeine. Adenosine induced an in-
crease in pulse pressure. During the highest infusion rate, SBP 
rose from 108.0±4.3 to 125.8+5.7 mm Hg (P<0.001), whereas DBP 
fell from 67.6±2.7 to 63.2±2.7 mm Hg (0.05<P<0.10). Adenosine 
infusion did not induce changes in MAP. A strong rise in HR from 
61.2±1.6 to 94.0±5.6 bpm occurred (P<0.001). The fractional rises 
in SBP and HR correlated significantly (r=0.71, P<0.025). After 
finishing adenosine infusion, pulse pressure decreased again, and 
HR also returned to basal values within 15 minutes. Figure 4 
shows some peripheral blood flow parameters before, during and 
after adenosine, preceded by administration of placebo or 
caffeine. During the highest infusion rate FBF was decreased, and 
calculated FVR was increased (P<0.05 ). Skin temperature fell 
from 34.3+0.5 to 32.2+0.1°С (P<0.05), and T
c
p02 initially 
showed an increase and at the highest rate a fall to about basal 
values. After the end of adenosine infusion, FBF, FVR and ST 
recovered rapidly. 
Table I shows the changes of humoral variables in the 2 adeno-
sine-tests. During the infusion rate of 0.16 mg/kg/min. an in­
crease in plasma adenosine was not observed, but the degradation 
products inosine and hypoxanthine both showed a significant rise. 
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Table I: Mean values (±5EM) of all humoral parameters before and during continuous infusion of adenosine after 
previous administration of placebo or caffeine. 
CAFFEINE 
NOREPINEPHRINE (nmol/l) 
EPINEPHRINE (nmol/l) 
PRA (ng/ml.hr-1) 
ALDOSTERONE (ng/100 ml) 
POTASSIUM (mmol/1) 
ADENOSINE (μπιοΐ/ΐ) 
INOSINE (μπιοΐ/ΐ) 
HYPOXANTHINE (μπιοΐ/ΐ) 
PLACEBO 
before 
0.2±00 
0.65+0.07 
0.13+0.04 
1.40±0.28 
5.2+1.0 
4.0±0.1 
1.28±0.52 
0.16±0.01 
0.39±0.07 
after 
0.2±00 
0.69+O.Oa 
0.12±0.03 
1.3*±0.26 
4.9±0.8 
4.0±0.1 
1.03±0.34 
0.17±0.02 
0.44±0.13 
ADENOSINE 
during 
0.1±00 
2.03±0.26** 
0.32+0.05** 
1.21+0.19 
6.6±1.6 
4.2±0.1 
1.40±0.45 
1.83+0.48** 
6.31±0.79** 
PLACEBO 
before 
0.1±0.1 
0.84±0.08 
0.12±Q.03 
2.08±0.27 
9.7±1.3 
4.0+0.1 
0.65+0.17 
0.15±0.00 
0.75+0.14 
after 
5.2±0.6*** 
0.94+0.10 
0.21±0.05* 
1.71+0.20 
7.0±1.2* 
4.1+0.1 
0.66±0.19 
0.17±0.01 
0.49±0.08 
ADtNOSINE 
during 
4.0±0.4*** 
1.73±0.25** 
0.29+0.06** 
1.03+0.12* 
6.1±1.0** 
4.2+0.1 
1.28+0.40 
2.54±0.49** 
7.26±0.55** 
*P < 0.05, **P < 0.01, ***P < 0.001 vs values before placebo or caffeine 
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As a matter of course plasma caffeine remained low throughout 
this test. Plasma epinephrine and norepinephrine showed incre-
ments of respectively 21 5 . 9±43 . B% and 227 . 2±64 . 655. No significant 
correlations were found between the rise of catecholamines and 
hemodynamic changes. Plasma aldosterone and plasma potassium did 
not change significantly, when compared to basal values. During 
the 2 highest infusion rates of adenosine all subjects had some 
of the following symptoms: flushing, palpitations, nausea, and a 
discomfort in the head, the neck, the chest and the abdomen. 
The circulatory effects of adenosine after caffeine 
The basal values of all hemodynamic and humoral parameters 
were not significantly different in the 2 adenosine-tests, with 
the exception of basal PRA (table I). Figure 3 and 4 present that 
the hemodynamic responses to adenosine infusion show a more or 
less similar pattern after previous placebo or caffeine admini-
stration. However, figure 5 shows differences between the 
adenosine-induced fractional changes in blood pressure and HR 
during each infusion rate after placebo and caffeine. After 
caffeine the adenosine-induced rise in SBP and HR are signifi-
cantly lower when compared to placebo and for these parameters 
the dose-response curve of adenosine is shifted to the right by 
caffeine. No differences were found with respect to DBP and MAP. 
figure 6 shows adenosine-induced fractional changes after placebo 
and caffeine for all peripheral blood flow parameters. The 
percentual fall of Tcp02 during the highest infusion rates of 
adenosine was significantly reduced after previous infusion of 
caffeine. Changes of FBF, calculated FVR and ST due to adenosine 
were not altered by caffeine. 
Changes of plasma adenosine, inosine and hypoxanthine during 
infusion of adenosine were not significantly altered by caffeine 
(table I). The mean rise of plasma caffeine in the caffeine-
adenoaine-test was similar as in the caffeine-test. Figure 7 
presents the fractional changes due to adenosine of catechol-
amines, PRA and aldosterone after placebo and caffeine. The 
adenosine-induced rise in catecholamines was significantly 
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attenuated by caffeine. Moreover, caffeine altered the response 
of PRA and of aldosterone to continuous infusion of adenosine. 
DISCUSSION 
This study indicates that the circulatory effects of adenosine 
are partly inhibited by caffeine, and until now this never has 
been reported in man. The dosage of caffeine used (250 mg) is 
equivalent to 2 or 3 cups of coffee, and our present results of 
single caffeine infusion closely agree with the rise of blood 
pressure and plasma epinephrine as has been observed after oral 
intake of coffee or caffeine (3,5,23). The pressor response to 
caffeine has been reported to be the result of an increase of 
total peripheral resistance (4). We hardly perceived a fall of 
FBF after caffeine, and according to the literature both caffeine 
and theophylline even increase FBF slightly (3,24). Consequently, 
the suggested vasoconstriction after caffeine seems not to be 
located in the forearm muscle. 
In the present study a complex hemodynamic response occurred 
during continuous infusion of adenosine. In literature only one 
report deals with these effects, and a strong fall of mean blood 
pressure (-435Í), with only a moderate increase of heart rate 
(+16SS) was observed (25). However, those subjects were anesthe-
tized with the use of several drugs, and consequently the normal 
cardiovascular reflex mechanisms may have been blunted. The same 
applies to a report on adenosine infusion in anesthetized dogs 
(B). In our study no premedication was used and we observed a 
pronounced tachycardia (+60.2±8.9л), with only a slight fall in 
diastolic blood pressure (-7.7+2.45») and no change in mean blood 
pressure during the highest adenosine infusion rate. This hemo­
dynamic response and the rise in plasma catecholamines indicate a 
stimulation of the sympathoadrenal system. Since adenosine itself 
even inhibits adrenergic neurotransmitter release (12,26), we 
think this must be caused by a cardiovascular reflex reaction to 
adenosine-induced regional vasodilation. Our results are insuffi­
cient to localize this vasodilation, but in-vivo studies suggest 
that this is most evident in the splanchnic vaacular bed (27). 
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During the highest adenosine infusion rates the parameters of 
peripheral blood flow showed a fall, suggesting local vasocon­
striction in the forearm muscle and the skin (28,29). Apparently, 
infusion of adenosine in man may elicit opposite responses in 
different vascular beds. Currently, 2 kinds of punnergic 
Pl-receptors are sensitive to adenosine, one leading to reduced 
and the other to enhanced cAMP accumulation, respectively Αχ- and 
A2-adenosine receptors (12,30). This may be the pharmacological 
ground for opposite responses to adenosine as well as caffeine in 
different tissues. Otherwise, the rise of catecholamines during 
adenosine-infusion could be another explanation for the vasocon­
striction in forearm muscle and skin, via o-adrenoceptor-mediated 
vasoconstriction. 
No significant increase of plasma adenosine concentration 
could be demonstrated in our venous samples. The plasma half-life 
of adenosine has been reported to be less than 10 seconds, and 
since the adenosine degradation products inosine and hypoxanthine 
are hemodynamically inactive (12), we must assume that increased 
concentrations of adenosine have circulated in the arterial 
system and were broken down by adenosine deaminase or taken up by 
blood cells before entering the venous system. Indeed, we obser­
ved significant rises of both inosine and hypoxanthine after 
infusion of adenosine (table I). 
The primary aim of this study was to look for antagonism of 
exogenous adenosine and caffeine in man. Because of the assumed 
compensatory stimulation of the sympathoadrenal system mean blood 
pressure failed to decrease after adenosine, and so the antago­
nism between caffeine and adenosine cannot be demonstrated by 
showing a reduction of adenosine-induced hypotension after 
caffeine as was found in rats (31). However, caffeine signifi­
cantly diminished the signs of compensatory reflex mechanisms, 
indicating a reduced adenosine-induced regional vasodilation. For 
systolic blood pressure and heart rate the dose-response curve of 
adenosine was shifted to the right after caffeine and this fits 
with the concept of a competitive antagonism between caffeine and 
adenosine on putative cardiovascular punnergic receptors. Being 
aware of the spontaneous fall of PRA during experiments in the 
morning hours (3), the effects of adenosine infusion on PRA and 
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aldosterone after placebo and caffeine may agree with the 
interpretation that caffeine reduced the stimulation of the 
renin-angiotensin-aldosterone system caused by adenosine-mediated 
local vasodilation. 
This study shows evidence for antagonism between caffeine, in 
concentrations likely to occur in daily life, and exogenous 
adenosine with respect to the cardiovascular system in man. If 
this interaction also holds for endogenous adenosine such an 
antagonism could explain the pressor response to coffee and 
caffeine. Since adenosine is a strong coronary vasodilator 
(8,32), the hemodynamic antagonism between caffeine and endo-
genous adenosine would also imply a vasoconstricting effect of 
caffeine on human coronary arteries. Additionally, adenosine has 
been reported to play a physiological role in control of the 
heart during stress via presynaptic inhibition of neurotrans-
mitter-release (12,26), and this may also be blunted by caffeine. 
Throughout the world caffeine is widely consumed, and in the USA 
coffee consumption accounts for nearly 80% of total caffeine 
intake (33). Therefore the effects of caffeine on blood pressure, 
and the hypothetical coronary vasoconstriction and impaired 
cardiac stress tolerance after caffeine could all form patho-
physiological substrates for the repeatedly suggested (34) and 
recently affirmed (35) epidemiological association between coffee 
consumption and cardiovascular morbidity or mortality. Electro-
physiological effects of caffeine (36), and its effects on blood 
lipids (37) could also contribute to this association. On the 
other hand, caffeine ingestion could theoretically exert benefi-
cial effects, since for example the sick-sinus syndrome, and the 
post-prandial depressor response in autonomic failure both could 
be adenosine-mediated (13,15). Indeed, caffeine 250 mg daily, has 
recently been reported to attenuate the postprandial fall of 
blood pressure in autonomic failure (38). Because of these 
hypothetical clinical consequences of caffeine ingestion, we 
think that further human studies on caffeine and adenosine have 
to be performed to asses both the harmfull and beneficial effects 
of caffeine in the management of cardiovascular disease. 
In conclusion, infusion of adenosine in man exerts a complex 
hemodynamic response with an increase in SBP and HR, a moderate 
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fall in DBP and signs of vasoconstriction in forearm muscle and 
skin. According to changes of catecholamines, PRA and aldosterone 
the sympathoadrenal system and to a lesser extent the renin-
angiotensin-aldosterone system seemed to be stimulated during 
adenosine infusion. We have demonstrated that these compensatory 
mechanisms to a presumed adenosine-mediated regional vasodila­
tion, were significantly reduced after previous administration of 
caffeine. These results indicate an antagonism between caffeine 
and adenosine in man, affirming the hypothesis that caffeine 
exerts its circulatory effects by competition with endogenous 
adenosine on purinergic cardiovascular receptors. Furthermore, 
this finding implies that the daily habit of drinking coffee 
could influence several physiological and pathophysiological 
adenosine-mediated processes of the cardiovascular system. 
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CHAPTER Vili 
GENERAL DISCUSSION AND CONCLUSIONS 
There are many contradictions in the literature concerning the 
consequences of drinking coffee for the cardiovascular system. In 
pharmacological studies caffeine has been reported to elevate, to 
lower and not to alter blood pressure, and the same contra-
dictions exist with respect to the effects of caffeine on heart 
rate (1-5). From an epidemiological point of view, a positive 
association between blood pressure and coffee consumption has 
been reported recently (6,7). However, most of the epidemio-
logical studies have focussed on the relation between coffee 
ingestion and morbidity or mortality from coronary heart disease. 
Although there is still no unanimity, the majority of these 
reports do not support a significant association between coffee 
and coronary heart disease (8,9). 
In chapter II we observed a rise in blood pressure, a fall in 
heart rate and a rise in plasma catecholamines (especially adre-
naline) after coffee, whereas decaffeinated coffee only induced a 
small rise in diastolic blood pressure. The results of the coffee 
tests after placebo pretreatment in the other studies (chapter 
IV and V) confirm this caffeine-mediated pressor effect of 
drinking coffee. The most striking effect was the rise in 
diastolic blood pressure, amounting up to 20% in the 2n^ hour 
after drinking coffee. The results of chapter II, IV and V were 
obtained after a caffeine abstinence of at least 18-24 hours. 
Although such caffeine abstentions may occur, the majority of 
coffee users probably do not reach such periods of caffeine 
abstinence in daily life. Indeed, the observation of tolerance or 
adaptation to the circulatory effects of caffeine ingestion after 
chronic caffeine intake, suggests that drinking coffee will not 
elevate blood pressure in daily life (10,11). This tolerance may 
partly explain all contradictory results concerning the cardio-
vascular effecta of coffee and caffeine (10,12). In chapter III 
we ascertained that the rise in blood presaure after coffee 
correlates negatively with basal plasma caffeine concentration. 
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Consequently, the pressor response to coffee is related to prior 
caffeine use and to individual pharmacokinetic properties. These 
findings suggest that despite the phenomenon of tolerance, 
drinking coffee may result in relevant rises of blood pressure 
during daily life in a considerable fraction of the population. 
It has to be emphasized that we could not demonstrate princi-
pal differences in the cardiovascular response to coffee between 
normotensive and hypertensive subjects (chapter V I ) . Since the 
decrease of blood pressure during most antihypertensive regimens 
averages 10-20Í» (13), the observed coffee-induced rise in blood 
pressure could nullify the results of treatment. Furthermore, the 
pressor response to coffee seemed not to be diminished by 
antihypertensive agents like propranolol, metoprolol or verapamil 
(chapter IV and V ) , nor by chronic diuretic treatment (14). 
Clinicians dealing with the problem of high blood pressure should 
be aware of these findings because the pressor response to coffee 
may interfere with the interpretation of blood pressure measure-
ments and results of treatment. 
In our studies coffee induced a 2 to 3-fold rise of plasma 
adrenaline, and a small or even no rise of noradrenaline. 
Although adrenaline may be regarded as а ^ 2 ~ а с ' г е п о с е Р ^ о г mediated 
vasodilator, it may be changed into an unopposed α-adrenoceptor 
mediated vasoconstrictor during non-selective ß-blockade, whereas 
this has not been found after ß 1-selective-adrenoceptor-blockade 
(15). Consequently, pretreatment with propranolol may increase 
the pressor response to coffee. However, according to the results 
in chapter IV propranolol does not change the coffee-induced 
response of blood pressure and forearm blood flow when compared 
to placebo or metoprolol pretreatment. Houben et al. ascertained 
that plasma adrenaline had to rise up to 200-400% before 
non-selective ß-blockade altered the vasodilatory response to 
adrenaline in a vasoconstrictor у one (15). In the experiments of 
chapter IV drinking coffee raised plasma adrenaline with 160%, 
and so the stress-stimulus was likely to be too small to reveal 
differences in hemodynamics between the propranolol-, and 
metoprololtest s. Indeed, after longer caffeine abstention, we 
observed rises in plasma adrenaline up to 260% (chapter V ) . 
Theoretically, propranolol could have increased the coffee-
Θ2 
induced pressor response in this group of subjects. Nevertheless, 
as such long caffeine abstinences ( >24 hours) are not likely to 
occur in daily life, we have found no evidence for the conclusion 
that treatment with p1-selective blockers should be preferred 
over non-selective fj-blockade in patients with hypertension or 
angina pectoris, who habitually use coffee. 
In figure 3 of chapter I, some suggested modes of action of 
caffeine with respect to its circulatory effects are summarized. 
The results of coffee tests in adrenalectomised patients indicate 
that drinking coffee elevates blood pressure independently of 
plasma adrenaline, but that the coffee-induced rise in circu-
lating adrenaline may facilitate the pressor response to coffee 
in healthy subjects (chapter VI). Furthermore, our data failed to 
demonstrate an important role of the renin-angiotensin-
aldosterone system in the circulatory effects of coffee. In 
chapter V we have described coffee tests in normotensive subjects 
with and without pretreatment with the calcium slow-channel 
blocker verapamil. We conclude that the role of calcium in the 
cardiovascular effects of drinking coffee, if any, should be of 
intracellular origin but appeared not to concern changes of 
transmembrane calcium influx. This thesis does not comprise data 
with respect to the inhibition of the enzyme phosphodiesterase by 
caffeine. In vitro such an inhibition only occurs at caffeine 
concentrations, which are 10 times higher than those reached 
after drinking coffee (16) and so this mode of action seems 
unlikely to be of importance with respect to our findings. 
In all recent reports on the effects of caffeine in man the 
antagonism of endogenous adenosine is mentioned as the mode of 
action most likely to be involved. However, those suggestions are 
all based on in-vitro studies (17) or on experiments in animals 
(18), but no human studies have been performed. In chapter VII we 
have shown that the circulatory effects of exogenous adenosine in 
man were attenuated after previous administration of caffeine. 
This observation may indicate that caffeine indeed exerts its 
circulatory effects by antagonizing the vasodilatory effects of 
endogenous adenosine. 
In conclusion, drinking coffee exerts a pressor response in 
normotensive as well as hypertensive subjects, combined with a 
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moderate fall in heart rate. The extent of the pressor response 
appears to depend on basal plasma caffeine level and thus on 
both, prior caffeine use and individual pharmacokinetics of 
caffeine. Further, drinking coffee exerts a rise of plasma 
adrenaline. Despite increased levels of circulating adrenaline 
after coffee, we observed no harmful fortification of the 
coffee-induced pressor response during non-selective ß-blockade 
with propranolol. 
The circulatory effects of caffeine are not mediated by the 
sympathoadrenal system or the г піп-angiotensin-aldosterone sys­
tem. In addition, the increase in transmembrane calcium influx 
appeared to be of no relevance for the circulatory effects of 
drinking coffee. Finally, we have observed an interaction of 
caffeine and exogenous adenosine in normotensive volunteers, 
supporting the hypothesis that caffeine may bring about its 
circulatory effects via an antagonism of endogenous adenosine. 
Since adenosine has been reported to be involved in several 
physiological and pathophysiological processes (19,20,21), the 
antagonism as shown in our study could be of importance with 
respect to developments in clinical pharmacological research on 
caffeine and other methylxanthines. 
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SAMENVATTING 
In onze samenleving wordt Coffeine op grote schaal gebruikt. 
De voornaamste bron vormt het dagelijks kopje koffie, maar 
Coffeine bevindt zich ook in thee, coca cola, cacao, chocolade en 
sommige pijnstillende middelen. Eén kopje koffie bevat gemiddeld 
ongeveer 90 mg Coffeine, maar dit kan, afhankelijk van de berei-
dingswijze, variëren van 30 tot 1Θ0 mg. Het verband tussen het 
drinken van koffie en de hoogte van de bloeddruk vormt al lang 
een dankbaar onderwerp voor zowel epidemiologische als farmaco­
logische studies. De resultaten van laatstgenoemde studies over 
de effecten van koffie en Coffeine op het hart- en vaatstelsel 
zijn erg controversieel. Zo zijn er in verachillende proefop­
stellingen zowel stijgingen als dalingen van bloeddruk en hart-
frequentie waargenomen na inname van Coffeine. Op epidemiologisch 
gebied gelden dezelfde tegenstrijdigheden. In enkele bevolkings­
studies is een relatie gevonden tussen kofflegebruik en de hoogte 
van de bloeddruk. Ook is in verschillende studies een verband 
tussen ko ffleconsumptie en het voorkomen van en de sterfte aan 
hart- en vaatziekten vastgesteld, maar andere onderzoekers ont­
kennen dit weer. Theoretisch kan het gebruik van koffie tenminste 
op een drietal manieren in een verhoogde sterfte aan hart- en 
vaatziekten resulteren: 1) Coffeine leidt tot een verhoging van 
de bloeddruk en/of van het lipoproteïnegehalte van het bloed, 
beide bekende risicofactoren voor het ontstaan van hart- en 
vaatziekten; 2) Coffeine veroorzaakt veranderingen van electro-
fysiologische eigenschappen van het hart (ritmestoornissen); 3) 
Coffeine of andere bestanddelen van koffie kunnen een direct 
effect hebben op al dan niet bekende pathofysiologische 
mechanismen van hart- en vaatziekten. 
stu 
de 
In dit proefschrift hebben 
idiea naar de effecten van 
wij 
koff 
ons beperkt to 
ie en Coffeine 
hart τrequentie, de spierdoorbl 
humorale, circulatoire parame 
in 
and 
is 
hoeverre deze parameters 
erzijds wat het farmacolog 
ters 
won 
isch 
met betrekking tot deze verandi 
. De 
den 
wer 
ВГ1П 
oeding en 
vraagstell 
beinvloed 
t farmacologische 
op 
op 
ing 
door 
kingsmechanisme 
gen. 
de bloeddruk, 
een aantal 
was enerzijds 
Coffeine en 
van Coffeine 
87 
In hoofdstuk II werden de hemodynamische en humorale effecten 
van het drinken van koffie vergeleken met die van co ffeïnevηje 
koffie. Na een co ffeïneonthouding van 17 uur verhoogde het drin-
ken van koffie de bloeddruk (diastolisch sterker dan systolisch), 
terwijl de hartfrequentie licht daalde. Tevens werd een stijging 
waargenomen van de concentraties van catecholaminen in het plasma 
(met name van het adrenaline). Co f feïnevn j e koffie gaf geen 
hemodynamische of humorale veranderingen, met uitzondering van 
een geringe stijging van de diastolische bloeddruk. Deze resul-
taten geven aan dat de effecten van het drinken van koffie op 
bloeddruk, hartfrequentie en piasmacatecholaminen toegeschreven 
kunnen worden aan de farmacologisch actieve stof coffeïne. 
Eerder hebben andere onderzoekers aangetoond dat bij chronisch 
gebruik een aantal effecten van coffeïne verminderen of zelfs 
verdwijnen, met andere woorden er treedt gewenning op. Het is nu 
de vraag of bij regelmatig co ffeïnegebruik, zoals in het dage-
lijkse leven gebruikelijk is, het drinken van koffie nog aantoon-
bare circulatoire effecten geeft. Hiertoe werden in hoofdstuk III 
de cardiovasculaire effecten van koffie gemeten na een relatief 
korte periode van coffeïneonthouding. Aangezien de snelheid waar-
mee coffeïne uit het bloed verdwijnt van mens tot mens sterk 
verschilt, werd de duur van de coffeïneonthouding afhankelijk 
gesteld van de tevoren voor ieder individu bepaalde verdwijnings-
snelheid . 
Acht gezonde vrijwilligers, die deelnamen aan het eerste deel 
van dit onderzoek, varieerden inderdaad sterk in de eliminatie 
hal fwaardeti jd voor coffeïne, en wel van 2 tot tí.5 uur. Hierbij 
bleek dat het drinken van 2 koppen koffie na een coffeïne-
onthouding van 4 maal de coffeïnehalfwaardetijd nog resulteerde 
in een stijging van de bloeddruk (diastolisch tot 2 0 % ) . Dit 
effect werd niet waargenomen wanneer in een identieke proefop-
stelling coffeïnevnje koffie, warm water of geheel niets werd 
toegediend. In een tweede deel van dit onderzoek werd in een 
groep van 30 vrijwilligers, na een willekeurige periode van 
coffeïneonthouding, een negatieve correlatie gevonden tussen de 
procentuele bloeddrukstijging na koffie en de basale plasma-
coffeineconcentratie. De bloeddrukstijging na het drinken van 
koffie is dus zowel afhankelijk van het voorafgaand coffeïne 
ΘΘ 
gebruik als van de individuele farmacokinetiek voor Coffeine. Wij 
hebben aannemelijk kunnen maken dat ondanks het beschreven adap-
tatiefenomeen, het dagelijks drinken van koffie voor een deel van 
de bevolking aanleiding kan geven tot een belangrijke stijging 
van de bloeddruk. 
De resultaten van hoofdstuk VI laten onder meer zien dat de 
cardiovasculaire effecten van het drinken van koffie bij hyper-
tensiepatiënten even uitgesproken zijn als bij gezonde vrijwil-
ligers. Bovendien wijzen eigen gegevens en die uit de literatuur 
erop dat de bloeddrukstijging na Coffeine niet verminderd wordt 
door het gebruik van bloeddrukverlagende medicamenten zoals 
propranolol en metoprolol (hoofdstuk IV), verapamil (hoofdstuk V) 
en chloorthalidon. Voor artsen die betrokken zijn bij de behan-
deling van hypertensie kunnen deze resultaten van belang zijn bij 
de interpretatie van bloeddrukmetingen en van resultaten van 
therapie, te meer omdat de bloeddrukstijging na koffiegebruik in 
dezelfde orde van grootte ligt als de gemiddelde daling tijdens 
chronische antihypertensieve therapie. Onze gegevens kunnen 
tevens een gedeeltelijke verklaring vormen voor de vele tegen-
strijdigheden in epidemiologisch onderzoek naar het verband 
tussen coffeinegebruik enerzijds, en de hoogte van de bloeddruk 
en het optreden van hart- en vaatziekten anderzijds. 
Het drinken van koffie geeft een stijging van plasmacatechol-
aminen en met name van het adrenalinegehalte (stress-hormoon). 
Uit vorig onderzoek van onze afdeling (proefschriften van C. van 
Herwaarden en van H. Houben) is bekend dat behandeling van hyper-
tensie met zogenaamde met-selectieve ß-blokkers in combinatie 
met verhoogde adrenaline-spiegels ("stress") kan leiden tot een 
ongunstige bloeddrukstijging, terwijl dit niet optreedt na behan-
deling met p-j-selectieve blokkers. Bij de door Coffeine geïndu-
ceerde stijging van adrenaline konden wij deze ongunstige veran-
deringen niet waarnemen bij proefpersonen die koffie dronken na 
kortdurende voorbehandeling met de met-selectieve ß-blokker 
propranolol. De bloeddrukeffecten waren gelijk aan die na een 
placebo of na de ßi -selectieve blokker metoprolol. Gezien deze 
bevindingen zijn ß-|-selectieve blokkerende middelen dan ook niet 
zonder meer te verkiezen boven met-selectieve ß-blokkers bij de 
behandeling van patiënten met hypertensie of angina pectoris, die 
regelmatig koffie drinken. 
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In figuur 3 van hoofdstuk I wordt een aantal mogelijke farma-
cologische werkingsmechanismen van Coffeine opgesomd, die in de 
loop der jaren in de literatuur zijn genoemd. De meerderheid van 
deze voorgestelde mechanismen vloeit voort uit resultaten van 
in-vitro studies of van dierexperimenten en met betrekking tot de 
cardiovasculaire effecten van Coffeine bij de mens zijn deze 
mechanismen dan ook nog louter hypothetisch. Verschillende onder-
zoekers hebben de circulatoire effecten van Coffeine toegeschre-
ven aan een directe invloed op belangrijke bloeddrukregulerende 
systemen, zoals het autonome (sympathische) zenuwstelsel en het 
renine-anglotensine-aldosteron systeem. De resultaten van de 
kof fletoediening bij gezonde vrijwilligers (hoofdstuk II t/m V) 
en bij patiënten die geen adrenaline meer produceren vanwege een 
doorgemaakte bijnieroperatie (bilaterale adrenalectomie, 
hoofdstuk VI) tonen aan dat de hemodynamische effecten van het 
drinken van koffie niet primair een gevolg kunnen zijn van een 
stimulatie van een van beide genoemde systemen. In hoofdstuk V 
worden de circulatoire effecten van koffie bestudeerd na voor-
behandeling met de calciuminstroomblokker verapamil. De verande-
ringen van de bloeddruk, de hart frequent ie en de plasmacatechol-
aminen na kofflegebruik werden niet gewijzigd door voorafgaande 
toediening van verapamil. Dit maakt een directe invloed van 
coffeïne op de calciuminflux over de celmembraan eveneens tot een 
minder waarschijnlijk werkingsmechanisme. De invloed van Coffeine 
op de intracellulaire verschuivingen van calcium (zie figuur 3 
van hoofdstuk I) is niet als zodanig bestudeerd, en hierover kan 
dan ook geen uitsluitsel worden gegeven. Dit geldt eveneens voor 
de weergegeven centrale werkingsmechanismen. 
De laatste jaren komen steeds meer dierexperimentele gegevens 
ter beschikking die erop wijzen dat Coffeine en verwante stoffen 
zoals theophylline hun effect sorteren via antagonisme van de 
endogene vaatverwijdende stof adenosine. Met betrekking tot de 
hemodynamische effecten van Coffeine bij de mens was dit antago-
nisme tot op heden niet bestudeerd. In hoofdstuk VII is de 
interactie tussen Coffeine en exogeen toegediend adenosine bij 
gezonde vrijwilligers bestudeerd. De hemodynamische en humorale 
effecten van adenosine bleken geremd te kunnen worden door voor-
afgaande intraveneuze toediening van Coffeine. Deze resultaten 
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geven steun aan de hypothese dat het drinken van koffie bloed-
drukverhogend werkt via remming van de endogene vaatverwijder 
adenosine. Aangezien de laatste jaren blijkt dat adenosine waar-
schijnlijk betrokken is bij een aantal fysiologische en patho-
fysiologische processen van het hart- en vaatstelsel, kan dit 
antagonisme tussen Coffeine en adenosine bij de mens van belang 
zijn bij ontwikkelingen op het gebied van de cardiovasculaire 
farmacotherapie. 
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jaar Biologie (faculteit der Wis- & Natuurwetenschappen) aan de 
Universiteit te Nijmegen. In 1976 begon hij met zijn studie in de 
Geneeskunde aan dezelfde Universiteit, waar hij in 19B1 het 
doctoraalexamen en in 19Θ3 het artsexamen aflegde. Sinds 
september 19Θ3 is hij in opleiding tot internist op de afdeling 
Inwendige Geneeskunde van het Sint Radboud ziekenhuis te Nijmegen 
(hoofd: Prof. Dr. A. van 't Laar). 
Hij is getrouwd met Liesbet Korebnts. Zij hebben een zoon, Loek. 
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STELLINGEN 
I 
De stijging van de bloeddruk en die van het pi asma-adrenal ine-
gehalte na het drinken van koffie zijn voornamelijk het gevolg 
van de farmacologisch actieve stof Coffeine. 
(dit proefschrift) 
II 
De hemodynamische en humorale reactie op intraveneuze infusie van 
adenosine kan geremd worden door Coffeine. Dit steunt de hypo-
these dat de cardiovasculaire effecten van Coffeine tenminste 
gedeeltelijk berusten op antagonisme van endogeen adenosine. 
(dit proefschrift) 
III 
De bloeddrukstijging na het drinken van koffie is geringer naar-
mate het coffeïnegehalte in het bloed vóór het drinken van koffie 
hoger is. De grootte van deze bloeddrukstijging 13 dus afhanke-
lijk van voorafgaand co ffeïnegebrui к en van de individuele 
halfwaardetijd voor Coffeine. 
(dit proefschrift) 
IV 
De circulatoire effecten van Coffeine worden niet primair veroor­
zaakt door een stimulatie van het sympathische zenuwstelsel, het 
bijniermerg of het renine-angiotensine-aldosteron systeem. 
(dit proefschrift) 
V 
Bij een recidief van acute leukemie blijkt de duur van de eerste 
complete remissie een prognostische betekenis te hebben voor het 
bereiken van een tweede complete remissie. 
(P. Smits, L. Schoots, B. de Pauw et al. Prognostic factors 
in adult patients with acute leukemia at first relapse. 
Aangeboden voor publicatie.) 
VI 
Neurohypofysaire diabetes insipidus kan een vroeg symptoom zijn 
van leukemie. 
(eigen waarneming) 
VII 
Medicamenteuze behandeling van lichte hypertensie verlaagt de 
incidentie van cerebrovasculaire accidenten. 
(Medical research council working party. MRC trial of mild 
hypertension: principal results. Br.Med.J. 19 5; 291: 97-104) 
VIII 
Bij patiënten met asthma bronchiale is de bronchusverwijdende 
werking van enprofylline 3 tot 5 maal sterker dan die van theo-
phylline. Aangezien enprofylline in vitro veel minder in staat is 
om de effecten van adenosine te antagoneren dan theophylline, is 
het dan ook onwaarschijnlijk dat laatstgenoemd mechanisme 
bijdraagt aan de anti-asthma effecten van χ anthinederivaten. 
(Laursen et al. Intravenous administration of enprofylline to 
asthmatic patients. Eur.J.CI in.Pharmacol . 1983; 24: 323-327) 
IX 
Het star vasthouden aan het verrichten van lichamelijk onderzoek 
vanuit de rechterzijde van de patient is in de literatuur over 
fysische diagnostiek onvoldoende onderbouwd, en kan ongemakkelijk 
zijn voor arts en patient. Het verdient dan ook overweging om 
medisch studenten wat dit betreft zowel links- als rechtshändig 
opteleiden. 
(Akgün S. Left may be right, too. N.Eng.J.Med.1986; 314: 994) 
De verminderde sympathicusactivi teit na ß-adrenoceptor-
blokkerende stoffen is m e t altijd alleen het gevolg van een com-
petitieve binding van de ß-Ыоккег aan de ß-adrenerge receptor, 
maar kan ook berusten op een vermindering van het aantal ß-adre-
nerge receptoren. 
(De Blasie et al. Reduction of beta-adrenergic receptors by 
tertatolol: an additional mechanism for beta-adrenergic 
blockade.Clin.Pharm.4Ther.1986; 39: 245-254) 
XI 
Bij bejaarden met diabetes mellitus is het voorschrijven van een 
dieet in het algemeen niet zinvol, en vaak zelFs schadelijk. 
XII 
Ook voor koffie lijkt te gelden: "what is true about nutrition is 
not really sensational, and what is sensational about nutrition 
is not really true" . 
(naar Victor Herbert) 
Nijmegen, 19Θ6 Paul Smits 



